Skip to main content
Deutsches Ärzteblatt International logoLink to Deutsches Ärzteblatt International
. 2018 Sep 28;115(39):639–645. doi: 10.3238/arztebl.2018.0639

The Improvement of Walking Ability Following Stroke

A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials

Jan Mehrholz 1,2,*, Marcus Pohl 3, Joachim Kugler 1, Bernhard Elsner 1,2
PMCID: PMC6224539  PMID: 30375325

Abstract

Background

Gait velocity and maximum walking distance are central parameters for measuring the success of rehabilitation of gait after a stroke. The goal of this study was to provide an overview of current evidence on the rehabilitation of gait after a stroke.

Methods

A systematic review of randomized, controlled trials was carried out using network meta-analysis. The primary endpoint was gait velocity; secondary endpoints were the ability to walk, maximum walking distance, and gait stability. The following interventions were analyzed: no gait training, conventional gait training (reference category), training on a treadmill with or without body weight support, training on a treadmill with or without a speed paradigm, and electromechanically assisted gait training with end-effector or exoskeleton apparatus.

Results

The systematic search yielded 40 567 hits. 95 randomized, controlled trials involving a total of 4458 post-stroke patients were included in the meta-analysis. With respect to the primary endpoint of gait velocity, gait training assisted by end-effector apparatus led to significant improvement (mean difference [MD] = 0.16 m/s; 95% confidence interval [0.04; 0.28]). None of the other interventions improved gait velocity to any significant extent. With respect to one of the secondary endpoints, maximum walking distance, both gait training assisted by end-effector apparatus and treadmill training with body weight support led to significant improvement (MD = 47 m, [4; 90], and MD = 38 m, [4; 72], respectively). A network meta-analysis could not be performed with respect to the ability to walk (a different secondary endpoint) because of substantial inconsistencies in the data. The interventions did not differ significantly with respect to safety.

Conclusion

In comparison to conventional gait rehabilitation, gait training assisted by end-effector apparatus leads to a statistically significant and clinically relevant improvement in gait velocity and maximum walking distance after stroke, while treadmill training with body weight support leads to a statistically significant and clinically relevant improvement in maximum walking distance.


Stroke is one of the most frequently occurring diseases worldwide and leads to permanent disability, diminished quality of life, and thus to a heavy burden of illness. A high proportion of stroke patients have impaired walking ability and can only walk in their own home. Their reduced mobility often means they are unable to go outdoors at all. Approximately 70% of those who retain the ability to walk cannot move at a normal speed and are therefore limited in daily activities such as crossing the road at a stop light (1). Regaining the ability to walk at a speed approaching normal is thus one of the principal goals for stroke patients and their family members.

In recent years interventions such as treadmill training and electromechanical-assisted training have been introduced to help improve walking after stroke (2). During treadmill training the patient is secured by a belt system that bears part of the body weight (3, 4). Another approach is treadmill training with systematic increase of the walking speed (5). In electromechanical-assisted training the patient’s gait cycle is partly automated, which eases the work of the therapist (6). This method increases the number of steps that can be taken during treatment sessions and enables severely affected patients to practice walking earlier and more intensively than was possible previously (7). The GT-1 walking trainer is an example of the end-effector type (1), while exoskeleton models are represented by the Lokomat and LOPES trainers (6, 8). Moreover, studies published particularly in the past few years have described mobile exoskeletons (911) and special “limb robots” (1214).

The exoskeleton system consists of a treadmill and an exoskeleton, i.e., an orthosis with rods and joints designed to imitate the skeleton of the lower extremities that is adapted to the dimensions of each individual patient (1). Integrated into the exoskeleton are programmable power units that move the hip and knee joints during ambulation. The feet are also led or controlled by the device (1). In the end-effector system the patient, secured by straps, stands on two footplates that simulate walking (1). The device moves only the feet, fixed to the footplates; The knee and hip joints follow and are not controlled by the device but have to be actively moved by the patient (1).

Although the evidence on training stroke patients to walk seems robust, no review has yet been compiled that summarizes and evaluates the results of all studies and interventions regarding the improvement of walking ability after a stroke. The existing Cochrane Reviews, for example, have a narrow focus such as the efficacy of treadmill training or the efficacy of electromechanical-assisted rehabilitation of walking (4, 15). However, there are hardly any comparisons of two or more interventions to improve walking ability, although in practice it is crucial to know which device performs more effectively than others in a given situation. The treating physician also encounters difficulties in deciding which specific form of treatment to prescribe for a stroke patient.

An approach to solving this problem is offered by network meta-analyses. These enable quantitative synopsis of the “evidence network” by combining direct and indirect comparisons of three or more interventions in randomized, controlled trials on the basis of a common comparative intervention (16).

Goals

We set out to gain an overview of the evidence from randomized, controlled trials on the improvement of walking speed, walking distance, walking ability, and safety in stroke patients. A further aim was to estimate the relative efficacy of the various interventions, taking effect modifiers into account.

Method

Study protocol and registration

The study protocol for this systematic review is registered in the PROSPERO database under the ID CRD42017056820 and meets the PRISMA criteria (17).

Inclusion and exclusion criteria

Our analysis embraced all published and unpublished studies on adults following stroke (clinically defined). We compared all types of training designed to improve the walking speed, walking distance, and walking ability of stroke patients. All randomized, controlled trials of parallel-group design and randomized crossover studies that compared walking training with other interventions were included. We combined comparable interventions and approaches into treatment categories.

Endpoints

The primary endpoint was walking speed, while the secondary endpoints were walking ability, walking distance, and walking safety.

Interventions

We defined the following categorization of study interventions in advance:

  • No walking training

  • Conventional training (walking on the floor, preparatory exercises in sitting position, balance training etc. without technical aids and without treadmill training or electromechanical-assisted training) (reference category)

  • Treadmill training without or with body-weight support

  • Treadmill training with or without walking speed paradigm

  • Electromechanical-assisted training with end-effector devices or exoskeletons

The methods used for tracing of information sources and systematic literature screening, together with the procedures for statistical evaluation (1826), are described in detail in the eMethods.

Results

Our systematic survey yielded 44 567 records. After exclusion of irrelevant records, 95 randomized controlled trials with a total of 4458 patients were included for quantitative analysis (figure 1).

Figure 1.

Figure 1

Flow chart of systematic literature survey

Study characteristics

Of the 95 publications included, 80% were randomized controlled trials and the remaining 20% were randomized crossover studies. The trial size ranged from five to 282 patients (mean: 26 patients). The patients’ mean age ranged from 43 to 76 years (etable 1). The mean time elapsed since stroke was 3 days to 8 years. Altogether, 92 of the 95 trials compared an active experimental group with an active control group (eTables 24).

eTable 1. Study characteristics and results for the primary endpoint, walking speed.

Study Intervention Duration Frequency and time Mean (m/s) SD n Severity (able to walk unaided) Risk of bias (generation of randomization sequence) Risk of bias (concealment of randomization sequence) Risk of bias (blinding of investigators) Months after stroke
Ada 2003 Treadmill training with body-weight support 4 weeks 30 min 3× per week 0.75 0.26 11 No Low Low Low 28.00
Ada 2003 Conventional walking rehabilitation 4 weeks 30 min 3× per week 0.56 0.30 14 No Low Low Low 26.00
Ada 2013 Treadmill training with body-weight support 8 or 16 weeks 30 min 3× per week 0.64 0.35 68 Yes Low Low Low 21.00
Ada 2013 No walking rehabilitation 8 or 16 weeks 30 min 3× per week 0.55 0.28 34 Yes Low Low Low 19.00
Baer 2017 Treadmill training with body-weight support 8 weeks More than 2× per week 0.57 0.36 35 Yes Low Low Low 1.39
Baer 2017 Conventional walking rehabilitation 8 weeks More than 2× per week 0.59 0.43 34 Yes Low Low Low 1.32
Bang 2016 Electromechanical-assisted walking training with exoskeleton 4 weeks 60 min 5× per week 0.64 0.12 9 Yes Low Low Low 12.00
Bang 2016 Treadmill training 4 weeks 60 min 5× per week 0.55 0.12 9 Yes Low Low Low 13.00
Bonnyaud 2013 Treadmill training Single session 20 min 0.87 0.17 13 Unclear Unclear Unclear High 72.00
Bonnyaud 2013 Conventional walking rehabilitation Single session 20 min 0.89 0.17 13 Unclear Unclear Unclear High 72.00
Bonnyaud 2013a Treadmill training Single session 20 min 0.88 0.19 30 Yes Unclear Unclear High 72.00
Bonnyaud 2013a Conventional walking rehabilitation Single session 20 min 0.84 0.24 30 Yes Unclear Unclear High 72.00
Brincks 2011 Electromechanical-assisted walking training with exoskeleton 3 weeks Unclear 0.35 0.16 7 Yes Low Low High 1.84
Brincks 2011 Conventional walking rehabilitation 3 weeks Unclear 0.59 0.27 6 Yes Low Low High 0.69
Buesing 2015 Electromechanical-assisted walking training with exoskeleton 6 to 8 weeks 3× per week to max. 18 sessions 0.87 0.30 25 Yes Low High Low 84.00
Buesing 2015 Conventional walking rehabilitation 6 to 8 weeks 3× per week to max. 18 sessions 0.89 0.30 25 Yes Low High Low 60.00
Chua 2016 Electromechanical-assisted walking training with end-effector 8 weeks Unclear 0.56 0.45 53 No Low Low Low 0.89
Chua 2016 Conventional walking rehabilitation 8 weeks Unclear 0.63 0.60 53 No Low Low Low 0.99
Combs-Miller 2014 Treadmill training with body-weight support 2 weeks 30 min 5× per week 0.67 0.23 10 Yes Unclear Low Low 72.00
Combs-Miller 2014 Conventional walking rehabilitation 2 weeks 30 min 5× per week 0.79 0.28 10 Yes Unclear Low Low 60.00
da Cunha Filho 2002 Treadmill training with body-weight support 2 to 3 weeks 20 min 5× per week 0.32 0.42 6 No Low High High 0.52
da Cunha Filho 2002 Conventional walking rehabilitation 2 to 3 weeks 20 min 5× per week 0.26 0.25 7 No Low High High 0.62
Deniz 2011 Treadmill training with body-weight support 4 weeks 60 min 5× per week 0.49 0.18 10 Yes Unclear Unclear Unclear 2.33
Deniz 2011 Conventional walking rehabilitation 4 weeks 60 min 5× per week 0.24 0.13 10 Yes Unclear Unclear Unclear 2.66
DePaul 2015 Treadmill training with body-weight support 5 weeks Up to 30 min, up to 15 sessions 0.77 0.35 36 Yes Low Low Low 4.37
DePaul 2015 Conventional walking rehabilitation 5 weeks Up to 40 min, up to 15 sessions 0.69 0.31 35 Yes Low Low Low 4.14
Duncan 2011 Treadmill training with body-weight support 12 to 16 weeks 90 min 3× per week 0.24 0.22 282 No Unclear Low High 4.00
Duncan 2011 Conventional walking rehabilitation 12 to 16 weeks 90 min 3× per week 0.23 0.20 126 No Unclear Low High 2.00
Eich 2004 Treadmill training with body-weight support 6 weeks 30 min 5× per week 0.71 0.30 25 Yes Low Low Unclear 1.40
Eich 2004 Conventional walking rehabilitation 6 weeks 30 min 5× per week 0.60 0.22 25 Yes Low Low Unclear 1.45
Fisher 2008 Electromechanical-assisted walking training with exoskeleton 24 units 3–5× per week 0.18 0.23 10 Sometimes Unclear Unclear Low ND
Fisher 2008 Conventional walking rehabilitation 24 units 3–5× per week 0.18 0.20 10 Sometimes Unclear Unclear Low ND
Forrester 2014 Electromechanical-assisted walking training with exoskeleton 8 to 10 sessions 60 min 0.37 0.05 21 No Unclear High High 0.39
Forrester 2014 Conventional walking rehabilitation 8 to 10 sessions 60 min 0.34 0.05 18 No Unclear High High 0.36
Franceschini 2009 Treadmill training with body-weight support 5 weeks 60 min 5× per week 0.50 0.44 52 No Low Unclear Low 0.56
Franceschini 2009 Conventional walking rehabilitation 5 weeks 60 min 5× per week 0.60 0.44 50 No Low Unclear Low 0.46
Gama 2007 Treadmill training with body-weight support 6 weeks 45 min 3× per week 0.70 0.30 16 Yes Low Unclear High 60.00
Gama 2007 Conventional walking rehabilitation 6 weeks 45 min 3× per week 0.74 0.34 16 Yes Low Unclear High 54.00
Geroin 2011 Electromechanical-assisted walking training with end-effector 2 weeks 50 min 5× per week 0.59 0.28 20 Yes Low Low High 26.00
Geroin 2011 Conventional walking rehabilitation 2 weeks 50 min 5× per week 0.38 0.20 10 Yes Low Low High 27.00
Globas 2011 Treadmill training 12 weeks 30 to 50 min 3× per week 0.79 0.29 20 Yes Low Low High 60.00
Globas 2011 Conventional walking rehabilitation 13 weeks 60 min 3× per week 0.70 0.46 18 Yes Low Low High 70.00
Hidler 2009 Electromechanical-assisted walking training with exoskeleton 8 to 10 weeks 45 min 3× per week 0.46 0.18 36 Yes Low Unclear High 3.65
Hidler 2009 Conventional walking rehabilitation 8 to 10 weeks 45 min 3× per week 0.60 0.18 36 Yes Low Unclear High 4.57
Hornby 2008 Electromechanical-assisted walking training with exoskeleton 12 sessions 30 min 0.52 0.21 31 Yes Low Low High 50.00
Hornby 2008 Conventional walking rehabilitation 12 sessions 30 min 0.56 0.28 31 Yes Low Low High 73.00
Hoyer 2012 Treadmill training with body-weight support Minimum 10 weeks 30 min 2–3× per week 0.40 0.27 30 No Low Unclear Low 3.25
Hoyer 2012 Conventional walking rehabilitation Minimum 10 weeks 30 min 5× per week 0.36 0.24 30 No Low Unclear Low 3.16
Husemann 2007 Electromechanical-assisted walking training with exoskeleton 4 weeks 30 min 5× per week 0.20 0.12 17 No Low Low Low 2.60
Husemann 2007 Conventional walking rehabilitation 4 weeks 30 min 5× per week 0.20 0.18 15 No Low Low Low 2.93
Jaffe 2004 Treadmill training 2 weeks 60 min 3× per week 0.69 0.34 10 Yes High Unclear Low 46.80
Jaffe 2004 Conventional walking rehabilitation 2 weeks 60 min 3× per week 0.72 0.28 10 Yes High Unclear Low 43.20
Kang 2012 Treadmill training 4 weeks 30 min 3× per week 0.60 0.20 22 Yes Low Low Low 14.00
Kang 2012 Conventional walking rehabilitation 4 weeks 30 min 3× per week 0.50 0.10 10 Yes Low Low Low 15.00
Kim 2011 Treadmill training 6 weeks 30 min 5× per week 0.58 0.42 20 Yes Unclear High Unclear 15.00
Kim 2011 Conventional walking rehabilitation 6 weeks 30 min 5× per week 0.59 0.47 24 Yes Unclear High Unclear 14.00
Kosak 2000 Treadmill training with body-weight support 2 to 3 weeks 45 min 5× per week 0.06 0.18 22 No Low Low High 1.28
Kosak 2000 Conventional walking rehabilitation 2 to 3 weeks 45 min 5× per week 0.07 0.17 34 No Low Low High 1.32
Kuys 2011 Treadmill training with speed paradigm 6 weeks 30 min 3× per week 0.63 0.30 15 Yes Low Low Low 1.71
Kuys 2011 Conventional walking rehabilitation 6 weeks 30 min 3× per week 0.68 0.37 15 Yes Low Low Low 1.61
Kyung 2008 Electromechanical-assisted walking training with exoskeleton 4 weeks 45 min 3× per week 0.68 0.36 18 Sometimes Unclear Unclear Unclear 22.00
Kyung 2008 Conventional walking rehabilitation 4 weeks 45 min 3× per week 0.60 0.34 17 Sometimes Unclear Unclear Unclear 29.00
Langhammer 2010 Treadmill training Circa 10 units 30 min up to max. 5× per week 1.00 0.40 21 No Low Low Low 13.78
Langhammer 2010 Conventional walking rehabilitation Circa 11 units 30 min up to max. 5× per week 0.90 0.40 18 No Low Low Low 11.47
Laufer 2001 Treadmill training 3 weeks 8 to 20 min 5× per week 0.47 0.40 13 No High High Low 1.07
Laufer 2001 Conventional walking rehabilitation 3 weeks 8 to 20 min 5× per week 0.33 0.24 12 No High High Low 1.18
Liston 2000 Treadmill training 4 weeks 60 min 3× per week 0.67 0.33 7 Unclear Low High Low ND
Liston 2000 Conventional walking rehabilitation 4 weeks 60 min 3× per week 0.66 0.39 8 Unclear Low High Low ND
Luft 2008 Treadmill training 24 weeks 40 min 3× per week 0.82 0.50 57 Yes Low High Low 55.00
Luft 2008 Conventional walking rehabilitation 24 weeks 40 min 3× per week 0.71 0.50 56 Yes Low High Low 63.00
MacKay-Lyons 2013 Treadmill training with body-weight support 6 weeks 40 min 6× per week 0.75 0.22 24 Yes Low Low Low 0.76
MacKay-Lyons 2013 Conventional walking rehabilitation 6 weeks 40 min 6× per week 0.71 0.20 26 Yes Low Low Low 0.76
Macko 2005 Treadmill training 24 weeks 40 min 3× per week 0.95 0.45 25 Yes Low High Low 35.00
Macko 2005 Conventional walking rehabilitation 24 weeks 40 min 3× per week 1.00 0.49 20 Yes Low High Low 39.00
Mao 2015 Treadmill training with body-weight support 3 weeks 30 min 5× per week 0.50 0.20 15 No Unclear Unclear High 49.00
Mao 2015 Conventional walking rehabilitation 3 weeks 30 min 5× per week 0.33 0.12 14 No Unclear Unclear High 48.00
Middleton 2014 Treadmill training with body-weight support 1.5 weeks 60 min 5× per week 0.69 0.39 27 No High High Low 50.40
Middleton 2014 Conventional walking rehabilitation 1.5 weeks 60 min 5× per week 0.52 0.27 23 No High High Low 29.00
Moore 2010 Treadmill training with body-weight support 4 weeks 2–5× per week 0.63 0.30 15 Yes Unclear Unclear Unclear 13.00
Moore 2010 No walking rehabilitation ND ND 0.58 0.23 15 Yes Unclear Unclear Unclear 13.00
Morone 2011 Electromechanical-assisted walking training with end-effector 4 weeks 40 min 5× per week 0.43 0.16 24 No Low Low Low 0.62
Morone 2011 Conventional walking rehabilitation 4 weeks 40 min 5× per week 0.25 0.11 24 No Low Low Low 0.66
Nilsson 2001a Treadmill training with body-weight support 9 to 10 weeks 30 min 5× per week 0.51 0.40 24 No Low Low Low 0.72
Nilsson 2001a Conventional walking rehabilitation 9 to 10 weeks 30 min 5× per week 0.46 0.35 25 No Low Low Low 0.56
Nilsson 2001b Treadmill training with body-weight support 9 to 10 weeks 30 min 5× per week 0.78 0.30 8 Yes Low Low Low 0.72
Nilsson 2001b Conventional walking rehabilitation 9 to 10 weeks 30 min 5× per week 0.84 0.27 9 Yes Low Low Low 0.56
Noser 2012 Electromechanical-assisted walking training with exoskeleton Unclear Unclear 0.20 0.10 11 Yes Unclear Unclear Low 44.52
Noser 2012 Conventional walking rehabilitation Unclear Unclear 0.27 0.27 9 Yes Unclear Unclear Low 17.26
Ochi 2015 Electromechanical-assisted walking training with exoskeleton 4 weeks 20 min 5× per week 0.38 0.43 13 No Unclear Unclear Low 0.76
Ochi 2015 Conventional walking rehabilitation 4 weeks 20 min 5× per week 0.19 0.08 13 No Unclear Unclear Low 0.85
Olawale 2009 Treadmill training 12 weeks 25 min 3× per week 0.42 0.20 20 Yes Unclear Unclear Unclear 10.20
Olawale 2009 Conventional walking rehabilitation 12 weeks 25 min 3× per week 0.46 0.19 40 Yes Unclear Unclear Unclear 10.50
Park 2013 Treadmill training 1 week 2× 30 min 5 days per week 0.60 0.32 20 Yes Low Unclear High 21.00
Park 2013 Conventional walking rehabilitation 1 week 2× 30 min 5 days per week 0.60 0.32 20 Yes Low Unclear High 16.00
Park 2015 Treadmill training 3 weeks 30 min 5× per week 0.35 0.14 9 Yes High High High 10.00
Park 2015 Conventional walking rehabilitation 3 weeks 30 min 5× per week 0.32 0.16 10 Yes High High High 13.00
Peurala 2005 Electromechanical-assisted walking training with end-effector 3 weeks 20 min 5× per week 0.51 0.38 30 Sometimes Low Low High 30.00
Peurala 2005 Conventional walking rehabilitation 3 weeks 20 min 5× per week 0.39 0.20 15 Sometimes Low Low High 48.00
Pohl 2002 Treadmill training with speed paradigm 4 weeks 30 min 3× per week 1.43 0.79 40 Yes Unclear Unclear High 3.80
Pohl 2002 Conventional walking rehabilitation 4 weeks 45 min 3× per week 0.97 0.64 20 Yes Unclear Unclear High 3.71
Pohl 2007 Electromechanical-assisted walking training with end-effector 4 weeks 20 min 5× per week 0.44 0.47 77 No Low Low Low 0.97
Pohl 2007 Conventional walking rehabilitation 4 weeks 20 min 5× per week 0.32 0.36 78 No Low Low Low 1.04
Ribeiro 2013 Treadmill training with body-weight support 4 weeks 30 min 3× per week 0.50 0.20 13 Yes High High High 33.00
Ribeiro 2013 Conventional walking rehabilitation 4 weeks 30 min 3× per week 0.40 0.10 12 Yes High High High 20.00
Richards 1993 Treadmill training 5 weeks 105 min 5× per week 0.26 0.14 9 No Unclear Unclear Unclear 0.43
Richards 1993 Conventional walking rehabilitation 5 weeks 105 min 5× per week 0.31 0.20 9 No Unclear Unclear Unclear 0.43
Richards 2004 Treadmill training 8 weeks 60 min 5× per week 0.60 0.38 32 Yes Low Low Low 0.27
Richards 2004 Conventional walking rehabilitation 8 weeks 60 min 5× per week 0.57 0.35 31 Yes Low Low Low 0.29
Salbach 2004 Conventional walking rehabilitation 6 weeks 3× per week 0.99 0.56 44 Unclear Low Low Low 7.86
Salbach 2004 No walking rehabilitation 6 weeks 3× per week 0.80 0.49 47 Unclear Low Low Low 7.13
Saltuari 2004 Electromechanical-assisted walking training with exoskeleton 2 weeks ABA study; in phase A 30 min 5× per week 0.20 0.12 8 Sometimes Low Unclear Unclear 3.60
Saltuari 2004 Conventional walking rehabilitation 2 weeks ABA study; in phase A 30 min 5× per week 0.23 0.19 8 Sometimes Low Unclear Unclear 1.90
Srivastava 2016a Treadmill training with body-weight support 4 weeks 30 min 5× per week 0.46 0.27 13 No Low Unclear Low 12.88
Srivastava 2016a Treadmill training 4 weeks 30 min 5× per week 0.45 0.28 12 No Low Unclear Low 14.53
Srivastava 2016a Conventional walking rehabilitation 4 weeks 30 min 5× per week 0.55 0.25 15 No Low Unclear Low 21.44
Srivastava 2016b Electromechanical-assisted walking training with exoskeleton 3 weeks 40 min 5× per week 0.70 0.30 6 Unclear Unclear Unclear Unclear 53.80
Srivastava 2016b Treadmill training with body-weight support 3 weeks 40 min 5× per week 0.75 0.30 6 Unclear Unclear Unclear Unclear 15.30
Stein 2014 Electromechanical-assisted walking training with exoskeleton 6 weeks 60 min 3× per week 0.49 0.36 12 Yes Unclear Unclear Low 49.00
Stein 2014 Conventional walking rehabilitation 6 weeks 60 min 3× per week 0.52 0.25 12 Yes Unclear Unclear Low 89.00
Sullivan 2007 Treadmill training with body-weight support 6 weeks 60 min 4× per week 0.66 0.34 60 Yes Low Low Low 23.80
Sullivan 2007 Conventional walking rehabilitation 6 weeks 60 min 4× per week 0.44 0.28 20 Yes Low Low Low 28.40
Suputtitada 2004 Treadmill training with body-weight support 4 weeks 25 min 7× per week 0.49 0.23 24 Yes Unclear Unclear Low 27.30
Suputtitada 2004 Conventional walking rehabilitation 4 weeks 25 min 7× per week 0.28 0.16 24 Yes Unclear Unclear Low 21.60
Takami 2010 Treadmill training with body-weight support 4 weeks 30 min 3× per week 1.47 0.45 24 Yes Unclear Low Unclear 14.00
Takami 2010 Conventional walking rehabilitation 4 weeks 80 min 5–6× per week 1.11 0.49 12 Yes Unclear Low Unclear 13.70
Tanaka 2012 Conventional walking rehabilitation 4 weeks ABA study; in phase B 20 min circa 2–3× per week 0.85 0.45 7 Yes Low Unclear High 55.00
Tanaka 2012 No walking rehabilitation ND ND 0.88 0.15 5 Yes Low Unclear High 65.00
Thaut 1997 Treadmill training 6 weeks 60 min 5× per week 0.80 0.30 10 Unclear Unclear Unclear Low 0.53
Thaut 1997 Conventional walking rehabilitation 6 weeks 60 min 5× per week 0.53 0.17 10 Unclear Unclear Unclear Low 0.52
Thaut 2007 Treadmill training 3 weeks 30 min 5× per week 0.58 0.11 43 Unclear Unclear Low Low 0.70
Thaut 2007 Conventional walking rehabilitation 3 weeks 30 min 5× per week 0.34 0.11 35 Unclear Unclear Low Low 0.73
Tong 2006 Electromechanical-assisted walking training with end-effector 4 weeks 20 min 5× per week 0.51 0.31 33 No Low Low Low 0.58
Tong 2006 Conventional walking rehabilitation 4 weeks 20 min 5× per week 0.19 0.26 21 No Low Low Low 0.62
Van Nunen 2012 Electromechanical-assisted walking training with exoskeleton 8 weeks 30 min 2× per week 0.28 0.21 16 Sometimes Unclear Low High 2.10
Van Nunen 2012 Conventional walking rehabilitation 8 weeks 60 min 1× per week 0.27 0.21 14 Sometimes Unclear Low High 2.10
Wade 1992 Conventional walking rehabilitation Unclear Unclear 0.24 0.15 48 Yes Low Low Low 53.10
Wade 1992 No walking rehabilitation Unclear Unclear 0.21 0.17 41 Yes Low Low Low 59.60
Watanabe 2014 Electromechanical-assisted walking training with exoskeleton 4 weeks 20 min up to max. 12 sessions 0.85 0.43 17 No Low Unclear High 1.94
Watanabe 2014 Conventional walking rehabilitation 4 weeks 20 min up to max. 12 sessions 0.63 0.50 15 No Low Unclear High 1.68
Weng 2004 Treadmill training with body-weight support 4 weeks 20 min 5× per week 1.31 0.57 25 Yes Unclear Unclear Unclear 1.19
Weng 2004 Conventional walking rehabilitation 4 weeks 20 min 5× per week 0.86 0.38 25 Yes Unclear Unclear Unclear 1.17
Weng 2006 Treadmill training 3 weeks 30 min 5× per week 0.95 0.28 13 Yes Low Low Unclear 2.04
Weng 2006 Conventional walking rehabilitation 3 weeks 60 min 5× per week 0.72 0.27 13 Yes Low Low Unclear 2.07
Werner 2002a Treadmill training with body-weight support 2 weeks 15 to 20 min 5× per week 0.07 0.19 15 No Low Low Unclear 1.70
Werner 2002a Electromechanical-assisted walking training with end-effector 2 weeks 20 min 5× per week 0.11 0.19 15 No Low Low Unclear 1.59
Westlake 2009 Electromechanical-assisted walking training with exoskeleton 4 weeks 30 min 3× per week 0.72 0.38 8 Yes Unclear Low High 44.00
Westlake 2009 Conventional walking rehabilitation 4 weeks 30 min 3× per week 0.65 0.29 8 Yes Unclear Low High 37.00
Yen 2008 Treadmill training with body-weight support 4 weeks 30 min 3× per week 0.92 0.32 7 Yes Low Low High 2.00
Yen 2008 Conventional walking rehabilitation 4 weeks 50 min 2–3× per week 0.87 0.43 7 Yes Low Low High 2.00
Zhu 2004 Treadmill training with body-weight support 4 weeks 5× per week 0.19 0.11 10 Unclear Low Unclear High 4.10
Zhu 2004 Conventional walking rehabilitation 4 weeks 5× per week 0.17 0.13 10 Unclear Low Unclear High 3.10

ABA, A-B-A study design (A = baseline phase, B = intervention phase); ND, no data; SD, standard deviation

eTable 2. Study characteristics and results for the secondary endpoint walking distance.

Study Intervention Duration Frequency and time Mean (m/s) SD n Severity (able to walk unaided) Risk of bias (generation of randomization sequence) Risk of bias (concealment of randomization sequence) Risk of bias (blinding of investigators) Months after stroke
Ada 2003 Treadmill training with body-weight support 4 weeks 30 min 3× per week 379 122 11 No Low Low Low 28.00
Ada 2003 Conventional walking rehabilitation 4 weeks 30 min 3× per week 269 123 14 No Low Low Low 26.00
Ada 2013 Treadmill training with body-weight support 8 or 16 weeks 30 min 3× per week 271 134 68 Yes Low Low Low 21.00
Ada 2013 No walking rehabilitation 8 or 16 weeks 30 min 3× per week 263 115 34 Yes Low Low Low 19.00
Baer 2017 Treadmill training with body-weight support 8 weeks More than 2× per week 132 114 35 Yes Low Low Low 1.39
Baer 2017 Conventional walking rehabilitation 8 weeks More than 2× per week 137 81 34 Yes Low Low Low 1.32
Chua 2016 Electromechanical-assisted walking training with end-effector 8 weeks Unclear 145 121 53 No Low Low Low 0.89
Chua 2016 Conventional walking rehabilitation 8 weeks Unclear 157 144 53 No Low Low Low 0.99
Combs-Miller 2014 Treadmill training with body-weight support 2 weeks 30 min 5× per week 249 116 10 Yes Unclear Low Low 72.00
Combs-Miller 2014 Conventional walking rehabilitation 2 weeks 30 min 5× per week 272 110 10 Yes Unclear Low Low 60.00
da Cunha Filho 2002 Treadmill training with body-weight support 2 to 3 weeks 20 min 5× per week 87 111 6 No Low High High 0.52
da Cunha Filho 2002 Conventional walking rehabilitation 2 to 3 weeks 20 min 5× per week 57 59 7 No Low High High 0.62
Deniz 2011 Treadmill training with body-weight support 4 weeks 60 min 5× per week 148 22 10 Yes Unclear Unclear Unclear 2.33
Deniz 2011 Conventional walking rehabilitation 4 weeks 60 min 5× per week 70 61 10 Yes Unclear Unclear Unclear 2.66
DePaul 2015 Treadmill training with body-weight support 5 weeks Up to 30 min, up to 15 sessions 239 120 36 Yes Low Low Low 4.37
DePaul 2015 Conventional walking rehabilitation 5 weeks Up to 40 min, up to 15 sessions 268 135 35 Yes Low Low Low 4.14
Duncan 2011 Treadmill training with body-weight support 12 to 16 weeks 90 min 3× per week 186 135 282 No Unclear Low High 4.00
Duncan 2011 Conventional walking rehabilitation 12 to 16 weeks 90 min 3× per week 202 144 126 No Unclear Low High 2.00
Eich 2004 Treadmill training with body-weight support 6 weeks 30 min 5× per week 199 81 25 Yes Low Low Unclear 1.40
Eich 2004 Conventional walking rehabilitation 6 weeks 30 min 5× per week 164 69 25 Yes Low Low Unclear 1.45
Frances-chini 2009 Treadmill training with body-weight support 5 weeks 60 min 5× per week 160 84 52 No Low Unclear Low 0.56
Frances-chini 2009 Conventional walking rehabilitation 5 weeks 60 min 5× per week 170 119 50 No Low Unclear Low 0.46
Gama 2007 Treadmill training with body-weight support 6 weeks 45 min 3× per week 291 148 16 Yes Low Unclear High 60.00
Gama 2007 Conventional walking rehabilitation 6 weeks 45 min 3× per week 283 139 16 Yes Low Unclear High 54.00
Globas 2011 Treadmill training 12 weeks 30 to 50 min 3× per week 332 138 20 Yes Low Low High 60.00
Globas 2011 Conventional walking rehabilitation 13 weeks 60 min 3× per week 266 189 18 Yes Low Low High 70.00
Hidler 2009 Electromechanical-assisted walking training with exoskeleton 8 to 10 weeks 45 min 3× per week 168 59 36 Yes Low Unclear High 3.65
Hidler 2009 Conventional walking rehabilitation 8 to 10 weeks 45 min 3× per week 218 64 36 Yes Low Unclear High 4.57
Hornby 2008 Electromechanical-assisted walking training with exoskeleton 12 sessions 30 min 186 88 31 Yes Low Low High 50.00
Hornby 2008 Conventional walking rehabilitation 12 sessions 30 min 204 96 31 Yes Low Low High 73.00
Hoyer 2012 Treadmill training with body-weight support Minimum 10 weeks 30 min 138 95 30 No Low Unclear Low 3.25
Hoyer 2012 Conventional walking rehabilitation Minimum 10 weeks 30 min 5× per week 115 84 30 No Low Unclear Low 3.16
Kang 2012 Treadmill training 4 weeks 30 min 3× per week 251 22 22 Yes Low Low Low 14.00
Kang 2012 Conventional walking rehabilitation 4 weeks 30 min 3× per week 241 22 10 Yes Low Low Low 15.00
Kim 2016 Treadmill training 4 weeks 30 min 3× per week 36 32 10 Yes Unclear Low Unclear 7.50
Kim 2016 Conventional walking rehabilitation 4 weeks 60 min 5× per week 33 48 17 Yes Unclear Low Unclear 14.94
Kosak 2000 Treadmill training with body-weight support 2 to 3 weeks 45 min 5× per week 23 76 22 No Low Low High 1.28
Kosak 2000 Conventional walking rehabilitation 2 to 3 weeks 45 min 5× per week 31 72 34 No Low Low High 1.32
Kuys 2011 Treadmill training with speed paradigm 6 weeks 30 min 3× per week 284 139 15 Yes Low Low Low 1.71
Kuys 2011 Conventional walking rehabilitation 6 weeks 30 min 3× per week 279 163 15 Yes Low Low Low 1.61
Langhammer 2010 Treadmill training Circa 10 units 30 min to max. 5× per week 321 154 21 No Low Low Low 13.78
Langham-mer 2010 Conventional walking rehabilitation Circa 11 units 30 min to max. 5× per week 310 164 18 No Low Low Low 11.47
Luft 2008 Treadmill training 24 weeks 40 min 3× per week 227 146 57 Yes Low High Low 55.00
Luft 2008 Conventional walking rehabilitation 24 weeks 40 min 3× per week 205 158 56 Yes Low High Low 63.00
MacKay-Lyons 2013 Treadmill training with body-weight support 6 weeks 40 min 6× per week 279 89 24 Yes Low Low Low 0.76
MacKay-Lyons 2013 Conventional walking rehabilitation 6 weeks 40 min 6× per week 232 80 26 Yes Low Low Low 0.76
Macko 2005 Treadmill training 24 weeks 40 min 3× per week 281 120 25 Yes Low High Low 35.00
Macko 2005 Conventional walking rehabilitation 24 weeks 40 min 3× per week 265 136 20 Yes Low High Low 39.00
Middleton 2014 Treadmill training with body-weight support 1.5 weeks 60 min 5× per week 338 204 27 No High High Low 50.40
Middleton 2014 Conventional walking rehabilitation 1.5 weeks 60 min 5× per week 239 166 23 No High High Low 29.00
Moore 2010 Treadmill training with body-weight support 4 weeks 2–5× per week 276 130 15 Yes Unclear Unclear Unclear 13.00
Moore 2010 No walking rehabilitation ND ND 201 134 15 Yes Unclear Unclear Unclear 13.00
Noser 2012 Electromechanical-assisted walking training with exoskeleton Unclear Unclear 57 26 11 Yes Unclear Unclear Low 44.52
Noser 2012 Conventional walking rehabilitation Unclear Unclear 70 60 9 Yes Unclear Unclear Low 17.26
Olawale 2009 Treadmill training 12 weeks 25 min 3× per week 145 75 20 Yes Unclear Unclear Unclear 10.20
Olawale 2009 Conventional walking rehabilitation 12 weeks 25 min 3× per week 146 65 40 Yes Unclear Unclear Unclear 10.50
Pang 2005 Conventional walking rehabilitation 19 weeks 60 min 3× per week 393 151 32 Yes Low Low Low 62.40
Pang 2005 No walking rehabilitation 19 weeks 60 min 3× per week 342 133 31 Yes Low Low Low 61.20
Park 2013 Treadmill training 1 week 2× 30 min, 5 days per week 234 42 20 Yes Low Unclear High 21.00
Park 2013 Conventional walking rehabilitation 1 week 2× 30 min, 5 days per week 225 47 20 Yes Low Unclear High 16.00
Park 2015 Treadmill training 3 weeks 30 min 5× per week 126 50 9 Yes High High High 10.00
Park 2015 Conventional walking rehabilitation 3 weeks 30 min 5× per week 123 39 10 Yes High High High 13.00
Peurala 2005 Electromechanical-assisted walking training with end-effector 3 weeks 20 min 5× per week 164 103 30 Sometimes Low Low High 30.00
Peurala 2005 Conventional walking rehabilitation 3 weeks 20 min 5× per week 135 68 15 Sometimes Low Low High 48.00
Picelli 2016 Electromechanical-assisted walking training with end-effector 1 week 30 min 5× per week 200 53 11 Yes Low Low Low 72.00
Picelli 2016 No walking rehabilitation ND ND 159 79 11 Yes Low Low Low 72.00
Pohl 2007 Electromechanical-assisted walking training with end-effector 4 weeks 20 min 5× per week 134 126 77 No Low Low Low 0.97
Pohl 2007 Conventional walking rehabilitation 4 weeks 20 min 5× per week 93 105 78 No Low Low Low 1.04
Salbach 2004 Conventional walking rehabilitation 6 weeks 3× per week 249 136 44 Unclear Low Low Low 7.86
Salbach 2004 No walking rehabilitation 6 weeks 3× per week 209 132 47 Unclear Low Low Low 7.13
Saltuari 2004 Electromechanical-assisted walking training with exoskeleton 2 weeks ABA study; in phase A 30 min 5× per week 81 62 8 Sometimes Low Unclear Unclear 3.60
Saltuari 2004 Conventional walking rehabilitation 2 weeks ABA study; in phase A 30 min 5× per week 58 43 8 Sometimes Low Unclear Unclear 1.90
Srivastava 2016a Treadmill training with body-weight support 4 weeks 30 min 5× per week 285 85 13 No Low Unclear Low 12.88
Srivastava 2016a Treadmill training 4 weeks 30 min 5× per week 279 72 12 No Low Unclear Low 14.53
Srivastava 2016a Conventional walking rehabilitation 4 weeks 30 min 5× per week 290 67 15 No Low Unclear Low 21.44
Srivastava 2016b Electromechanical-assisted walking training with exoskeleton 3 weeks 40 min 5× per week 260 110 6 Unclear Unclear Unclear Unclear 53.80
Srivastava 2016b Treadmill training with body-weight support 3 weeks 40 min 5× per week 258 72 6 Unclear Unclear Unclear Unclear 15.30
Stein 2014 Electromechanical-assisted walking training with exoskeleton 6 weeks 60 min 3× per week 213 108 12 Yes Unclear Unclear Low 49.00
Stein 2014 Conventional walking rehabilitation 6 weeks 60 min 3× per week 195 83 12 Yes Unclear Unclear Low 89.00
Sullivan 2007 Treadmill training with body-weight support 6 weeks 60 min 4× per week 236 126 60 Yes Low Low Low 23.80
Sullivan 2007 Conventional walking rehabilitation 6 weeks 60 min 4× per week 171 123 20 Yes Low Low Low 28.40
Toledano-Zarhi 2011 Treadmill training 6 weeks 90 min 2× per week 469 190 14 Yes Unclear Unclear Unclear 0.36
Toledano-Zarhi 2011 No walking rehabilitation ND ND 484 123 14 Yes Unclear Unclear Unclear 0.36
Waldman 2013 Electromechanical-assisted walking training with end-effector 6 weeks 60 min 3× per week 217 107 12 Yes Unclear High High 41.00
Waldman 2013 Conventional walking rehabilitation 6 weeks 60 min 3× per week 209 121 12 Yes Unclear High High 30.00
Watanabe 2014 Electromechanical-assisted walking training with exoskeleton 4 weeks 20 min to max. 12 sessions 157 138 17 No Low Unclear High 1.94
Watanabe 2014 Conventional walking rehabilitation 4 weeks 20 min to max. 12 sessions 135 132 15 No Low Unclear High 1.68
Westlake 2009 Electromechanical-assisted walking training with exoskeleton 4 weeks 30 min 3× per week 278 177 8 Yes Unclear Low High 44.00
Westlake 2009 Conventional walking rehabilitation 4 weeks 30 min 3× per week 212 114 8 Yes Unclear Low High 37.00

ABA, A-B-A study design (A = baseline phase, B = intervention phase); ND, no data; SD, standard deviation

eTable 4. Study characteristics and results for the secondary endpoint safety.

Study Intervention Duration Frequency and time e n Severity (able to walk unaided) Risk of bias (generation of randomization sequence) Risk of bias (concealment of randomization sequence) Risk of bias (blinding of investigators) Months after stroke
Ada 2003 Treadmill training with body-weight support 4 weeks 30 min 3× per week 3 14 No Low Low Low 28.00
Ada 2003 Conventional walking rehabilitation 4 weeks 30 min 3× per week 0 15 No Low Low Low 26.00
Ada 2010 Treadmill training with body-weight support 4 weeks 30 min 3× per week 0 64 No Low Low Low 0.59
Ada 2010 Conventional walking rehabilitation 4 weeks 30 min 3× per week 0 62 No Low Low Low 0.59
Aschbacher 2006 Electromechanical-assisted walking training with exoskeleton 3 weeks 30 min 5× per week 1 11 Sometimes Unclear Unclear Unclear Unclear
Aschbacher 2006 Conventional walking rehabilitation 3 weeks 30 min 5× per week 3 12 Sometimes Unclear Unclear Unclear Unclear
Baer 2017 Treadmill training with body-weight support 8 weeks More than 2× per week 2 35 Yes Low Low Low 1.39
Baer 2017 Conventional walking rehabilitation 8 weeks More than 2× per week 0 34 Yes Low Low Low 1.32
Bang 2016 Electromechanical-assisted walking training with exoskeleton 4 weeks 60 min 5× per week 0 9 Yes Low Low Low 12.00
Bang 2016 Treadmill training 4 weeks 60 min 5× per week 0 9 Yes Low Low Low 13.00
Brincks 2011 Electromechanical-assisted walking training with exoskeleton 3 weeks Unclear 0 7 Yes Low Low High 1.84
Brincks 2011 Conventional walking rehabilitation 3 weeks Unclear 0 6 Yes Low Low High 0.69
Buesing 2015 Electromechanical-assisted walking training with exoskeleton 6 to 8 weeks 3× per week to max. 18 sessions 0 25 Yes Low High Low 84.00
Buesing 2015 Conventional walking rehabilitation 6 to 8 weeks 3× per week to max. 18 sessions 0 25 Yes Low High Low 60.00
Chang 2012 Electromechanical-assisted walking training with exoskeleton 1.5 weeks 100 min 5× per week 3 24 Sometimes Unclear Unclear Unclear 0.53
Chang 2012 Conventional walking rehabilitation 1.5 weeks 100 min 5× per week 4 24 Sometimes Unclear Unclear Unclear 0.59
Cho 2015 Electromechanical-assisted walking training with exoskeleton 8 weeks 60 min 5× per week 0 13 No Unclear High High 15
Cho 2015 Conventional walking rehabilitation 8 weeks 60 min 5× per week 0 7 No Unclear High High 13
Chua 2016 Electromechanical-assisted walking training with end-effector 8 weeks Unclear 7 53 No Low Low Low 0.89
Chua 2016 Conventional walking rehabilitation 8 weeks Unclear 13 53 No Low Low Low 0.99
da Cunha Filho 2002 Treadmill training with body-weight support 2 to 3 weeks 20 min 5× per week 0 7 No Low High High 0.52
da Cunha Filho 2002 Conventional walking rehabilitation 2 to 3 weeks 20 min 5× per week 0 8 No Low High High 0.62
Dias 2006 Electromechanical-assisted walking training with end-effector 5 weeks 5× per week 0 20 Yes Unclear Low High 47.00
Dias 2006 Conventional walking rehabilitation 5 weeks 5× per week 0 10 Yes Unclear Low High 48.00
Duncan 2011 Treadmill training with body-weight support 12 to 16 weeks 90 min 3× per week 104 282 No Unclear Low High 4.00
Duncan 2011 Conventional walking rehabilitation 12 to 16 weeks 90 min 3× per week 35 126 No Unclear Low High 2.00
Eich 2004 Treadmill training with body-weight support 6 weeks 30 min 5× per week 0 25 Yes Low Low Unclear 1.40
Eich 2004 Conventional walking rehabilitation 6 weeks 30 min 5× per week 0 25 Yes Low Low Unclear 1.45
Fisher 2008 Electromechanical-assisted walking training with exoskeleton 24 units 3–5× per week 3 10 Sometimes Unclear Unclear Low Unclear
Fisher 2008 Conventional walking rehabilitation 24 units 3–5× per week 0 10 Sometimes Unclear Unclear Low Unclear
Forrester 2014 Electromechanical-assisted walking training with exoskeleton 8 to 10 sessions 60 min 3 21 No Unclear High High 0.39
Forrester 2014 Conventional walking rehabilitation 8 to 10 sessions 60 min 2 18 No Unclear High High 0.36
Franceschini 2009 Treadmill training with body-weight support 5 weeks 60 min 5× per week 2 52 No Low Unclear Low 0.56
Franceschini 2009 Conventional walking rehabilitation 5 weeks 60 min 5× per week 0 50 No Low Unclear Low 0.46
Gama 2007 Treadmill training with body-weight support 6 weeks 45 min 3× per week 0 16 Yes Low Unclear High 60.00
Gama 2007 Conventional walking rehabilitation 6 weeks 45 min 3× per week 0 16 Yes Low Unclear High 54.00
Geroin 2011 Electromechanical-assisted walking training with end-effector 2 weeks 50 min 5× per week 0 20 Yes Low Low High 26.00
Geroin 2011 Conventional walking rehabilitation 2 weeks 50 min 5× per week 0 10 Yes Low Low High 27.00
Han 2016 Electromechanical-assisted walking training with exoskeleton 4 weeks 60 min 5× per week 0 30 No Unclear Unclear Low 0.73
Han 2016 Conventional walking rehabilitation 4 weeks 60 min 5× per week 4 30 No Unclear Unclear Low 0.59
Hidler 2009 Electromechanical-assisted walking training with exoskeleton 8 to 10 weeks 45 min 3× per week 3 36 Yes Low Unclear High 3.65
Hidler 2009 Conventional walking rehabilitation 8 to 10 weeks 45 min 3× per week 6 36 Yes Low Unclear High 4.57
Hornby 2008 Electromechanical-assisted walking training with exoskeleton 12 sessions 30 min 4 31 Yes Low Low High 50.00
Hornby 2008 Conventional walking rehabilitation 12 sessions 30 min 10 31 Yes Low Low High 73.00
Husemann 2007 Electromechanical-assisted walking training with exoskeleton 4 weeks 30 min 5× per week 1 17 No Low Low Low 2.60
Husemann 2007 Conventional walking rehabilitation 4 weeks 30 min 5× per week 1 15 No Low Low Low 2.93
Jaffe 2004 Treadmill training 2 weeks 60 min 3× per week 0 11 Yes High Unclear Low 46.80
Jaffe 2004 Conventional walking rehabilitation 2 weeks 60 min 3× per week 0 12 Yes High Unclear Low 43.20
Kim 2011 Treadmill training 6 weeks 30 min 5× per week 0 20 Yes Unclear High Unclear 15.00
Kim 2011 Conventional walking rehabilitation 6 weeks 30 min 5× per week 0 24 Yes Unclear High Unclear 14.00
Kyung 2008 Electromechanical-assisted walking training with exoskeleton 4 weeks 45 min 3× per week 1 18 Sometimes Unclear Unclear Unclear 22.00
Kyung 2008 Conventional walking rehabilitation 4 weeks 45 min 3× per week 9 17 Sometimes Unclear Unclear Unclear 29.00
Laufer 2001 Treadmill training 3 weeks 8 to 20 min 5× per week 0 15 No High High Low 1.07
Laufer 2001 Conventional walking rehabilitation 3 weeks 8 to 20 min 5× per week 0 14 No High High Low 1.18
Liston 2000 Treadmill training 4 weeks 60 min 3× per week 2 10 Unclear Low High Low Unclear
Liston 2000 Conventional walking rehabilitation 4 weeks 60 min 3× per week 0 8 Unclear Low High Low Unclear
MacKay-Lyons 2013 Treadmill training with body-weight support 6 weeks 40 min 6× per week 0 24 Yes Low Low Low 0.76
MacKay-Lyons 2013 Conventional walking rehabilitation 6 weeks 40 min 6× per week 0 26 Yes Low Low Low 0.76
Macko 2005 Treadmill training 24 weeks 40 min 3× per week 11 32 Yes Low High Low 35.00
Macko 2005 Conventional walking rehabilitation 24 weeks 40 min 3× per week 0 29 Yes Low High Low 39.00
Mayr 2008 Electromechanical-assisted walking training with exoskeleton 8 weeks 45 min 5× per week 4 37 Sometimes Unclear Unclear Unclear Unclear
Mayr 2008 Conventional walking rehabilitation 8 weeks 45 min 5× per week 9 37 Sometimes Unclear Unclear Unclear Unclear
Morone 2011 Electromechanical-assisted walking training with end-effector 4 weeks 40 min 5× per week 12 24 No Low Low Low 0.62
Morone 2011 Conventional walking rehabilitation 4 weeks 40 min 5× per week 9 24 No Low Low Low 0.66
Nilsson 2001 Treadmill training with body-weight support 9 to 10 weeks 30 min 5× per week 0 36 No Low Low Low 0.72
Nilsson 2001 Conventional walking rehabilitation 9 to 10 weeks 30 min 5× per week 0 37 No Low Low Low 0.56
Noser 2012 Electromechanical-assisted walking training with exoskeleton Unclear Unclear 0 11 Yes Unclear Unclear Low 44.52
Noser 2012 Conventional walking rehabilitation Unclear Unclear 1 10 Yes Unclear Unclear Low 17.26
Ochi 2015 Electromechanical-assisted walking training with exoskeleton 4 weeks 20 min 5× per week 0 13 No Unclear Unclear Low 0.76
Ochi 2015 Conventional walking rehabilitation 4 weeks 20 min 5× per week 0 13 No Unclear Unclear Low 0.85
Peurala 2005 Electromechanical-assisted walking training with end-effector 3 weeks 20 min 5× per week 0 30 Sometimes Low Low High 30.00
Peurala 2005 Conventional walking rehabilitation 3 weeks 20 min 5× per week 0 15 Sometimes Low Low High 48.00
Peurala 2009 Electromechanical-assisted walking training with end-effector 3 weeks 55 min 3× per week 5 22 Sometimes Low Low High 0.26
Peurala 2009 Conventional walking rehabilitation 3 weeks 55 min 3× per week 4 34 Sometimes Low Low High 0.26
Picelli 2016 Electromechanical-assisted walking training with end-effector 1 Woche 30 min 5× per week 0 11 Yes Low Low Low 72.00
Picelli 2016 No walking rehabilitation ND ND 0 11 Yes Low Low Low 72.00
Pohl 2002 Treadmill training with speed paradigm 4 weeks 30 min 3× per week 1 44 Yes Unclear Unclear High 3.80
Pohl 2002 Conventional walking rehabilitation 4 weeks 45 min 3× per week 0 25 Yes Unclear Unclear High 3.71
Pohl 2007 Electromechanical-assisted walking training with end-effector 4 weeks 20 min 5× per week 5 77 No Low Low Low 0.97
Pohl 2007 Conventional walking rehabilitation 4 weeks 20 min 5× per week 6 78 No Low Low Low 1.04
Richards 1993 Treadmill training 5 weeks 105 min 5× per week 0 10 No Unclear Unclear Unclear 0.43
Richards 1993 Conventional walking rehabilitation 5 weeks 105 min 5× per week 0 8 No Unclear Unclear Unclear 0.43
Richards 2004 Treadmill training 8 weeks 60 min 5× per week 2 32 Yes Low Low Low 0.27
Richards 2004 Conventional walking rehabilitation 8 weeks 60 min 5× per week 1 31 Yes Low Low Low 0.29
Saltuari 2004 Electromechanical-assisted walking training with exoskeleton 2 weeks ABA study; in phase A 30 min 5× per week 0 8 Sometimes Low Unclear Unclear 3.60
Saltuari 2004 Conventional walking rehabilitation 2 weeks ABA study; in phase A 30 min 5× per week 0 8 Sometimes Low Unclear Unclear 1.90
Scheidt-mann 1999 Treadmill training with body-weight support 3 weeks 60 min 5× per week 0 15 No Unclear Unclear Unclear 1.71
Scheidtmann 1999 Conventional walking rehabilitation 3 weeks 60 min 5× per week 0 15 nein Unclear Unclear Unclear 1.71
Schwartz 2006 Electromechanical-assisted walking training with exoskeleton 6 weeks 3× per week 4 37 Sometimes Unclear Unclear Hoch 0.72
Schwartz 2006 Conventional walking rehabilitation 6 weeks 3× per week 2 30 Sometimes Unclear Unclear Hoch 0.79
Smith 2008 Treadmill training 4 weeks 12 sessions of 20 min 0 10 ja Unclear Unclear Hoch Unclear
Smith 2008 No walking rehabilitation ND ND 0 10 Yes Unclear Unclear High Unclear
Stein 2014 Electromechanical-assisted walking training with exoskeleton 6 weeks 60 min 3× per week 0 12 Yes Unclear Unclear Low 49.00
Stein 2014 Conventional walking rehabilitation 6 weeks 60 min 3× per week 0 12 Yes Unclear Unclear Low 89.00
Tanaka 2012 Conventional walking rehabilitation 4 weeks ABA study; in phase B 20 min circa 2–3× per week 0 7 Yes Low Unclear High 55.00
Tanaka 2012 No walking rehabilitation ND ND 0 5 Yes Low Unclear High 65.00
Toledano-Zarhi 2011 Treadmill training 6 weeks 90 min 2× per week 0 14 Yes Unclear Unclear Unclear 0.36
Toledano-Zarhi 2011 No walking rehabilitation ND ND 0 14 Yes Unclear Unclear Unclear 0.36
Tong 2006 Electromechanical-assisted walking training with end-effector 4 weeks 20 min 5× per week 0 33 No Low Low Low 0.58
Tong 2006 Conventional walking rehabilitation 4 weeks 20 min 5× per week 4 21 No Low Low Low 0.62
Ucar 2014 Electromechanical-assisted walking training with exoskeleton 2 weeks 30 min 5× per week 0 11 Yes Low Unclear Low Unclear
Ucar 2014 Conventional walking rehabilitation 2 weeks 30 min 5× per week 0 11 Yes Low Unclear Low Unclear
Van Nunen 2012 Electromechanical-assisted walking training with exoskeleton 8 weeks 30 min 2× per week 0 16 Sometimes Unclear Low High 2.10
Van Nunen 2012 Conventional walking rehabilitation 8 weeks 60 min 1× per week 0 14 Sometimes Unclear Low High 2.10
Visintin 1998 Treadmill training 6 weeks 20 min 4× per week 0 50 Sometimes Low Low Low 2.24
Visintin 1998 Treadmill training with body-weight support 6 weeks 20 min 4× per week 0 50 Sometimes Low Low Low 2.56
Waldman 2013 Electromechanical-assisted walking training with end-effector 6 weeks 60 min 3× per week 0 12 Yes Unclear High High 41.00
Waldman 2013 Conventional walking rehabilitation 6 weeks 60 min 3× per week 0 12 Yes Unclear High High 30.00
Watanabe 2014 Electromechanical-assisted walking training with exoskeleton 4 weeks 20 min, max. 12 sessions 6 17 No Low Unclear High 1.94
Watanabe 2014 Conventional walking rehabilitation 4 weeks 20 min, max. 12 sessions 4 15 No Low Unclear High 1.68
Werner 2002a Treadmill training with body-weight support 2 weeks 15 to 20 min 5× per week 0 15 No Low Low Unclear 1.70
Werner 2002a Electromechanical-assisted walking training with end-effector 2 weeks 20 min 5× per week 0 15 No Low Low Unclear 1.59
Westlake 2009 Electromechanical-assisted walking training with exoskeleton 4 weeks 30 min 3× per week 0 8 Yes Unclear Low High 44.00
Westlake 2009 Conventional walking rehabilitation 4 weeks 30 min 3× per week 0 8 Yes Unclear Low High 37.00

ABA, A-B-A study design (A = baseline phase, B = intervention phase); ND, no data; SD, standard deviation

Ninety-two (97%) of the 95 publications included reported proper generation of the randomization sequence, 72 (76%) stated adequate concealment of the randomization sequence, and 77 (81%) confirmed satisfactory blinding of the investigators. The methodological quality of the trials, depicted in eFigures 13 and eTables 24, was included as a covariable in the calculations (adjusted effect mass). SUCRA (surface under the cumulative ranking curve) presentation of the endpoints can be found in eTables 57.

eFigure 1.

Network diagram for the primary endpoint, walking speed

eFigure 1

Each intervention is presented as a node in the network. Direct comparisons between interventions are represented by the lines connecting the nodes.

Network plot of the evidence net of randomized trials for improvement of walking speed following stroke (75 trials with 3614 patients): The blue circles (nodes) represent the different treatment methods, while the connecting lines show the available direct pairwise comparisons between treatment methods. The assignment of interventions to nodes is as listed in the eMethods. The size of each node is proportional to the number of studies, and the thickness of the lines proportional to the inverse of the standard error of the comparisons. The colors of the lines show the mean risk of bias as measured with the Cochrane Risk of Bias Tool (green: low risk of bias; yellow: unclear risk of bias; red: high risk of bias).

KON Conventional walking rehabilitation
NONE No walking rehabilitation
TT_STT Treadmill training with speed paradigm
EGAIT_EXO Electromechanical-assisted training with exoskeleton
EGAIT_EE Electromechanical-assisted training with end-effector
TT_BWS Treadmill training with body-weight support
TT Treadmill training

eFigure 2.

Network diagram for the secondary endpoint walking distance

eFigure 2

Each intervention is presented as a node in the network. Direct comparisons between interventions are represented by the lines connecting the nodes.

Network plot of the evidence net of randomized trials for improvement of walking distance following stroke (44 trials with 2509 patients): The blue circles (nodes) represent the different treatment methods, while the connecting lines show the available direct pairwise comparisons between treatment methods. The assignment of interventions to nodes is as listed in the eMethods. The size of each node is proportional to the number of studies, and the thickness of the lines proportional to the inverse of the standard error of the comparisons. The colors of the lines show the mean risk of bias as measured with the Cochrane Risk of Bias Tool (green: low risk of bias; yellow: unclear risk of bias; red: high risk of bias).

KON Conventional walking rehabilitation
NONE No walking rehabilitation
TT_STT Treadmill training with speed paradigm
EGAIT_EXO Electromechanical-assisted training with exoskeleton
EGAIT_EE Electromechanical-assisted training with end-effector
TT_BWS Treadmill training with body-weight support
TT Treadmill training

eTable 5. SUCRA for the primary endpoint, walking speed.

Intervention SUCRA
Electromechanical-assisted walking training with end-effector 92.2
Treadmill training with speed paradigm 69.3
Treadmill training with body-weight support 69.1
Treadmill training 57.3
Electromechanical-assisted walking training with exoskeleton 23.5
No walking rehabilitation 20.0
Conventional walking rehabilitation 18.6

SUCRA is a relative ranking of the competing interventions on the basis of their surface under the cumulative ranking line. This represents the percent efficacy or safety of a given treatment in relation to an “ideal” treatment.

eTable 7. SUCRA for the secondary endpoint safety.

Intervention SUCRA
Electromechanical-assisted walking training with exoskeleton 88.6
Electromechanical-assisted walking training with end-effector 64.1
No walking rehabilitation 59.1
Treadmill training with speed paradigm 42.1
Conventional walking rehabilitation 41.1
Treadmill training with body-weight support 33.8
Treadmill training 21.3

SUCRA is a relative ranking of the competing interventions on the basis of their surface under the cumulative ranking line. This represents the percent efficacy or safety of a given treatment in relation to an “ideal” treatment.

Summary of network geometry

Walking speed was used as an endpoint in 75 studies with a total of 3614 patients. Most of the trials compared treadmill training against walking rehabilitation without treadmill training (Figure 2 and eFigures 15).

Figure 2.

Results of the interventions as Forest plot for the primary endpoint, walking speed

Figure 2

NONE No walking rehabilitation
EGAIT_EXO Electromechanical-assisted training with exoskeleton
TT Treadmill training
TT_BWS Treadmill training with body-weight support
TT_STT Treadmill training with walking speed paradigm
EGAIT_EE Electromechanical-assisted training with end-effector

eFigure 5.

Results of all interventions in direct comparison with one another as Forest plot for the primary endpoint, walking speed

eFigure 5

KON vs NONE Conventional walking rehabilitation versus no walking rehabilitation
TT Treadmill training
TT_BWS Treadmill training with body-weight support
EGAIT_EE Electromechanical-assisted training with end-effector
EGAIT_EXO Electromechanical-assisted training with exoskeleton
TT_STT Treadmill training with speed paradigm
TT vs KON Treadmill training versus conventional walking rehabilitation
TT_BWS Treadmill training with body-weight support
EGAIT_EE Electromechanical-assisted training with end-effector
EGAIT_EXO Electromechanical-assisted training with exoskeleton
TT_STT Treadmill training with speed paradigm
TT_BWS vs TT Treadmill training with body-weight support versus treadmill training
EGAIT_EE Electromechanical-assisted training with end-effector
EGAIT_EXO Electromechanical-assisted training with exoskeleton
TT_STT Treadmill training with speed paradigm
EGAIT_EE vs TT_BWS Electromechanical-assisted training with end-effector versus treadmill training with body-weight support
EGAIT_EXO Electromechanical-assisted training with exoskeleton
TT_STT Treadmill training with speed paradigm
EGAIT_EXO vs EGAIT_EE Electromechanical-assisted training with exoskeleton versus electromechanical-assisted training with end-effector
TT_STT Treadmill training with speed paradigm
TT_STT vs EGAIT_EXO Treadmill training with speed paradigm versus electromechanical-assisted training with exoskeleton

Walking distance was the secondary endpoint in 44 trials with a total of 2509 patients. In these studies too, the majority compared treadmill training against walking rehabilitation without treadmill training (Figure 3 and eFigure 6).

Figure 3.

Results of the interventions as Forest plot for the secondary endpoint walking distance

Figure 3

EGAIT_EXO Electromechanical-assisted training with exoskeleton
NONE No walking rehabilitation
TT_STT Treadmill training with walking speed paradigm
TT Treadmill training
TT_BWS Treadmill training with body-weight support
EGAIT_EE Electromechanical-assisted training with end-effector

eFigure 6.

Results of all interventions in direct comparison with one another as Forest plot for the secondary endpoint walking distance

eFigure 6

KON vs NONE Conventional walking rehabilitation versus no walking rehabilitation
TT Treadmill training
TT_BWS Treadmill training with body-weight support
EGAIT_EE Electromechanical-assisted training with end-effector
EGAIT_EXO Electromechanical-assisted training with exoskeleton
TT_STT Treadmill training with speed paradigm
TT vs KON Treadmill training versus conventional walking rehabilitation
TT_BWS Treadmill training with body-weight support
EGAIT_EE Electromechanical-assisted training with end-effector
EGAIT_EXO Electromechanical-assisted training with exoskeleton
TT_STT Treadmill training with speed paradigm
TT_BWS vs TT Treadmill training with body-weight support versus treadmill training
EGAIT_EE Electromechanical-assisted training with end-effector
EGAIT_EXO Electromechanical-assisted training with exoskeleton
TT_STT Treadmill training with speed paradigm
EGAIT_EE vs TT_BWS Electromechanical-assisted training with end-effector versus treadmill training with body-weight support
EGAIT_EXO Electromechanical-assisted training with exoskeleton
TT_STT Treadmill training with speed paradigm
EGAIT_EXO vs EGAIT_EE Electromechanical-assisted training with exoskeleton versus electromechanical-assisted training with end-effector
TT_STT Treadmill training with speed paradigm
TT_STT vs EGAIT_EXO Treadmill training with speed paradigm versus electromechanical-assisted training with exoskeleton

Achievement of walking ability was a secondary endpoint in 22 studies with a total of 1517 patients. Most of these trials compared electromechanical-assisted walking training with walking training that did not involve electromechanical assistance (eFigure 3 and eTable 3).

eFigure 3.

Network diagram for the secondary endpoint walking ability

eFigure 3

Each intervention is presented as a node in the network. Direct comparisons between interventions are represented by the lines connecting the nodes.

Network plot of the evidence net of randomized trials for improvement of walking ability following stroke (22 trials with 1517 patients): The blue circles (nodes) represent the different treatment methods, while the connecting lines show the available direct pairwise comparisons between treatment methods. The assignment of interventions to nodes is as listed in the eMethods. The size of each node is proportional to the number of studies, and the thickness of the lines proportional to the inverse of the standard error of the comparisons. The colors of the lines show the mean risk of bias as measured with the Cochrane Risk of Bias Tool (green: low risk of bias; yellow: unclear risk of bias; red: high risk of bias).

TT Treadmill training
KON Conventional walking rehabilitation
EGAIT_EXO Electromechanical-assisted training with exoskeleton
EGAIT_EE Electromechanical-assisted training with end-effector
TT_BWS Treadmill training with body-weight support

eTable 3. Study characteristics and results for the secondary endpoint walking ability.

Study Intervention Duration Frequency and time e n Severity (able to walk unaided) Risk of bias (generation of randomization sequence) Risk of bias (concealment of randomization sequence) Risk of bias (blinding of investigators) Months after stroke
Ada 2010 Treadmill training with body-weight support 4 weeks 30 min 3× per week 40 64 No Low Low Low 28.00
Ada 2010 Conventional walking rehabilitation 4 weeks 30 min 3× per week 48 62 No Low Low Low 26.00
Aschbacher 2006 Electromechanical-assisted walking training with exoskeleton 3 weeks 30 min 5× per week 0 11 Sometimes Unclear Unclear Unclear Unclear
Aschbacher 2006 Conventional walking rehabilitation 3 weeks 30 min 5× per week 0 12 Sometimes Unclear Unclear Unclear Unclear
Chang 2012 Electromechanical-assisted walking training with exoskeleton 1.5 weeks 100 min 5× per week 4 24 Sometimes Unclear Unclear High 0.53
Chang 2012 Conventional walking rehabilitation 1.5 weeks 100 min 5× per week 1 24 Sometimes Unclear Unclear High 0.59
da Cunha Filho 2002 Treadmill training with body-weight support 2 to 3 weeks 20 min 5× per week 3 6 No Low High High 0.52
da Cunha Filho 2002 Conventional walking rehabilitation 2 to 3 weeks 20 min 5× per week 3 7 No Low High High 0.62
Duncan 2011 Treadmill training with body-weight support 12 to 16 weeks 90 min 3× per week 135 282 No Unclear Low High 4.00
Duncan 2011 Conventional walking rehabilitation 12 to 16 weeks 90 min 3× per week 61 126 No Unclear Low High 2.00
Fisher 2008 Electromechanical-assisted walking training with exoskeleton 24 units 3–5× per week 9 10 Sometimes Unclear Unclear Low Unclear
Fisher 2008 Conventional walking rehabilitation 24 units 3–5× per week 9 10 Sometimes Unclear Unclear Low Unclear
Franceschini 2009 Treadmill training with body-weight support 5 weeks 60 min 5× per week 0 52 No Low Unclear Low 0.56
Franceschini 2009 Conventional walking rehabilitation 5 weeks 60 min 5× per week 0 50 No Low Unclear Low 0.46
Husemann 2007 Electromechanical-assisted walking training with exoskeleton 4 weeks 30 min 5× per week 0 17 No Low Low Low 2.60
Husemann 2007 Conventional walking rehabilitation 4 weeks 30 min 5× per week 0 15 No Low Low Low 2.93
Kosak 2000 Treadmill training with body-weight support 2 to 3 weeks 45 min 5× per week 20 22 No Low Low High 1.28
Kosak 2000 Conventional walking rehabilitation 2 to 3 weeks 45 min 5× per week 28 34 No Low Low High 1.32
Kyung 2008 Electromechanical-assisted walking training with exoskeleton 4 weeks 45 min 3× per week 12 18 Sometimes Unclear Unclear Unclear 22.00
Kyung 2008 Conventional walking rehabilitation 4 weeks 45 min 3× per week 7 17 Sometimes Unclear Unclear Unclear 29.00
Mayr 2008 Electromechanical-assisted walking training with exoskeleton 8 weeks 45 min 5× per week 9 37 Sometimes Unclear Unclear Unclear Unclear
Mayr 2008 Conventional walking rehabilitation 8 weeks 45 min 5× per week 7 37 Sometimes Unclear Unclear Unclear Unclear
Morone 2011 Electromechanical-assisted walking training with end-effector 4 weeks 40 min 5× per week 19 24 No Low Low Low 0.62
Morone 2011 Conventional walking rehabilitation 4 weeks 40 min 5× per week 10 24 No Low Low Low 0.66
Nilsson 2001a Treadmill training with body-weight support 9 to 10 weeks 30 min 5× per week 4 24 No Low Low Low 0.72
Nilsson 2001a Conventional walking rehabilitation 9 to 10 weeks 30 min 5× per week 4 25 No Low Low Low 0.56
Peurala 2005 Electromechanical-assisted walking training with end-effector 3 weeks 20 min 5× per week 14 30 Sometimes Low Low High 30.00
Peurala 2005 Conventional walking rehabilitation 3 weeks 20 min 5× per week 9 15 Sometimes Low Low High 48.00
Peurala 2009 Electromechanical-assisted walking training with end-effector 3 weeks 55 min 3× per week 5 22 Sometimes Low Low High 0.26
Peurala 2009 Conventional walking rehabilitation 3 weeks 55 min 3× per week 5 34 Sometimes Low Low High 0.26
Pohl 2007 Electromechanical-assisted walking training with end-effector 4 weeks 20 min 5× per week 41 77 No Low Low Low 0.97
Pohl 2007 Conventional walking rehabilitation 4 weeks 20 min 5× per week 17 78 No Low Low Low 1.04
Saltuari 2004 Electromechanical-assisted walking training with exoskeleton 2 weeks ABA study; in phase A 30 min 5× per week 1 8 Sometimes Low Unclear Unclear 3.60
Saltuari 2004 Conventional walking rehabilitation 2 weeks ABA study; in phase A 30 min 5× per week 1 8 Sometimes Low Unclear Unclear 1.90
Scheidtmann 1999 Treadmill training with body-weight support 3 weeks 60 min 5× per week 10 15 No Unclear Unclear Unclear 1.71
Scheidtmann 1999 Conventional walking rehabilitation 3 weeks 60 min 5× per week 11 15 No Unclear Unclear Unclear 1.71
Schwartz 2006 Electromechanical-assisted walking training with exoskeleton 6 weeks 3× per week 20 37 Sometimes Unclear Unclear High 0.72
Schwartz 2006 Conventional walking rehabilitation 6 weeks 3× per week 8 30 Sometimes Unclear Unclear High 0.79
Tong 2006 Electromechanical-assisted walking training with end-effector 4 weeks 20 min 5× per week 12 33 No Low Low Low 0.58
Tong 2006 Conventional walking rehabilitation 4 weeks 20 min 5× per week 6 21 No Low Low Low 0.62
Van Nunen 2012 Electromechanical-assisted walking training with exoskeleton 8 weeks 30 min 2× per week 12 16 Sometimes Unclear Low High 2.10
Van Nunen 2012 Conventional walking rehabilitation 8 weeks 60 min 1× per week 8 14 Sometimes Unclear Low High 2.10
Werner 2002a Treadmill training with body-weight support 2 weeks 15 to 20 min 5× per week 13 15 No Low Low Unclear 1.70
Werner 2002a Electromechanical-assisted walking training with end-effector 2 weeks 20 min 5× per week 10 15 No Low Low Unclear 1.59

ABA, A-B-A study design (A = baseline phase, B = intervention phase); SD, standard deviation

The secondary endpoint safety was reported in 57 trials with a total of 2889 patients, most of which compared electromechanical-assisted walking training with walking training that did not involve electromechanical assistance (Figure 4 and eFigure 7).

Figure 4.

Results of the interventions as Forest plot for the secondary endpoint safety

Figure 4

EGAIT_EXO Electromechanical-assisted training with exoskeleton
EGAIT_EE Electromechanical-assisted training with end-effector
NONE No walking rehabilitation
TT_BWS Treadmill training with body-weight support
TT_STT Treadmill training with walking speed paradigm
TT Treadmill training

eFigure 7.

Results of all interventions in direct comparison with one another as Forest plot for the secondary endpoint safety

eFigure 7

KON vs NONE Conventional walking rehabilitation versus no walking rehabilitation
TT Treadmill training
TT_BWS Treadmill training with body-weight support
EGAIT_EE Electromechanical-assisted training with end-effector
EGAIT_EXO Electromechanical-assisted training with exoskeleton
TT_STT Treadmill training with speed paradigm
TT vs KON Treadmill training versus conventional walking rehabilitation
TT_BWS Treadmill training with body-weight support
EGAIT_EE Electromechanical-assisted training with end-effector
EGAIT_EXO Electromechanical-assisted training with exoskeleton
TT_STT Treadmill training with speed paradigm
TT_BWS vs TT Treadmill training with body-weight support versus treadmill training
EGAIT_EE Electromechanical-assisted training with end-effector
EGAIT_EXO Electromechanical-assisted training with exoskeleton
TT_STT Treadmill training with speed paradigm
EGAIT_EE vs TT_BWS Electromechanical-assisted training with end-effector versus treadmill training with body-weight support
EGAIT_EXO Electromechanical-assisted training with exoskeleton
TT_STT Treadmill training with speed paradigm
EGAIT_EXO vs EGAIT_EE Electromechanical-assisted training with exoskeleton versus electromechanical-assisted training with end-effector
TT_STT Treadmill training with speed paradigm
TT_STT vs EGAIT_EXO Treadmill training with speed paradigm versus electromechanical-assisted training with exoskeleton

The network structure and geometry are described in more detail in the eMethods.

Synthesis

For the primary endpoint of walking speed, end-effector-assisted training achieved significantly greater improvements than conventional walking rehabilitation (mean difference [MD] = 0.16 m/s, 95% confidence interval [CI]: [0.04; 0.28]). None of the other interventions improved walking speed significantly (figure 2).

With regard to the secondary endpoint of walking distance, both end-effector-assisted training and treadmill training with body-weight support increased the distance walked significantly more than conventional walking rehabilitation (MD = 47 m, 95% CI: [4; 90] and MD = 38 m, 95% CI: [4; 72], respectively). No other interventions improved walking distance significantly in comparison with conventional walking rehabilitation (figure 3).

No network analysis was carried out for the secondary endpoint of walking ability owing to statistically relevant inconsistency; the central precondition of transitivity was infringed. No approach was statistically significantly superior to any other approach.

Altogether 42 studies with a total of 2207 patients were included for analysis. At the end of treatment 639 patients (29%) were able to walk. Seventy study arms with a total of 1572 patients investigated the efficacy of conventional walking rehabilitation, while 21 study arms with 415 patients examined the efficacy of treadmill training. A detailed account of all trials with regard to patient and study characteristics, age, interventions, and walking ability can be found in eTables 14.

As for the secondary endpoint of safety, we found no systematic differences among the various interventions for walking rehabilitation following stroke.

Our sensitivity analysis revealed no significant difference in study effects with regard to the methodological quality of the trials included.

Discussion

Our systematic review and network meta-analysis embraced a total of 95 trials with 4458 patients. The special feature of this network meta-analysis is that for the first time, competing methods for improvement in walking following stroke are evaluated together and rendered directly statistically comparable with one another, thus enabling nuanced assessment of their effect. Our work can be viewed as complementing the existing Cochrane Reviews. Evaluation of the network meta-analysis showed that electromechanical control of the leg from distal (the end-effector principle) improves walking speed significantly more than conventional walking rehabilitation. The mean increase of 0.16 m/s (corresponding to 0.58 km/h) achieved by end-effector-assisted training is clinically meaningful (27).

For walking distance, it emerged that both an end-effector method and treadmill training with body-weight support can be expected to be superior to conventional walking rehabilitation in increasing the distance walked. According to Flansbjer the smallest clinical improvement was 0.15 to 0.25 m/s in walking speed and 37 to 66 m in walking distance in the 6-minute walking test (27).

The mean improvement over conventional walking rehabilitation of 38 m and 47 m, respectively, in the 6-minute walking test lies in the lower range of clinical relevance but can still be regarded as meaningful (27).

No statements were made with regard to achievement of walking ability. We refrained from statistical evaluation because of the clear statistical inconsistency in the evidence network (26). The individual studies, the interventions used, and the patient characteristics were therefore described qualitatively instead (etable 3).

Overall, the number of adverse events was relatively low in all studies and the safety level therefore high. No systematic differences were found among the various interventions for walking training following stroke (etable 4).

Comparison of results with previously published data

Previous reviews of walking rehabilitation after stroke have had a much narrower focus, e.g., the efficacy of treadmill training (15), electromechanical-assisted training (4), or repetitive conventional training (28). The advantage and novelty of the network analysis presented here lie in its inclusion of randomized controlled trials on various methods of walking rehabilitation in one common statistical analysis.

It is well known that treadmill training is appropriate for stroke patients who can already walk (15), and electromechanical-assisted training above all for non-ambulant patients (15, 28). Our network analysis shows that distally supportive electromechanical-assisted training is best for increasing walking speed following stroke and treadmill training with body-weight support best for improving the walking distance. This analysis supplements the existing evidence with the confirmation that the walking training for stroke patients should be highly repetitive with (distal) partial support, rather than relying on complete assistance systems.

In agreement with earlier publications, our analysis points to superiority of walking training with end-effector devices over conventional walking rehabilitation (4, 6). However, there are no controlled trials directly comparing the efficacy of the various devices available.

Potential criticisms

We applied a systematic, comprehensive strategy to search various databases for published and ongoing trials. Nevertheless, publication bias cannot be entirely ruled out because negative results may not have been submitted for publication.

Inconsistent description of treatments by different authors could possibly have resulted in excessively heterogeneous intervention categories, which would limit the generalizability of the findings. However, prior to statistical evaluation we discussed how best to define the intervention groups and then compare them statistically.

One could argue that the treatments within both the control group and the experimental group were heterogeneous. However, on the basis of the information provided in the studies included we strove to categorize all treatments to the best of our ability.

The described effects of some individual interventions—for both walking speed and walking distance—were not only statistically significant but also clinically meaningful. However, no conclusions could be drawn for walking ability in general. We selected a conservative approach and did not perform a network analysis for this parameter; rather, we described the studies in qualitative terms.

It could be reasoned that the initial degree of disability following stroke was a source of bias in the joint analysis of all patients. In this network analysis we used walking ability as one aspect of disability following stroke and employed it as a covariable in the statistical evaluation. However, the fact that no account was taken of other variables, such as stroke site, may have distorted the results—although it is not clear in which direction.

A further potential criticism lies in our categorization of the selected interventions. It could be that certain assisted interventions were used particularly in more severely affected patients (e.g., those who could not walk), as recommended in the current guidelines. However, closer inspection of the studies shows that not all study authors adhered to the latest guideline recommendations. A glance at the tabulated presentation of the interventions in the individual trials (eTables 1 and 2) reveals that sometimes mildly affected patients were treated with robotic systems and severely affected patients with treadmill systems, contrary to the recommendations in the guidelines. The effect and the direction of such a distortion on the basis of the study data cannot be assessed with any accuracy.

One can also voice the criticism that we used only the mean values from each trial, not the data from every individual patient. Undoubtedly much more precise estimates of the different effects could have been made on the basis of individual patient data, but this exceeded the remit of our study.

Limitation

One limitation of our systematic review and network meta-analysis is that we did not include mobility, falls, and quality of life as endpoints. We chose to concentrate on endpoints clinically relevant to walking ability, i.e., walking speed and distance, that are also very important for patients in their recovery from stroke. Nevertheless, further studies should focus particularly on other endpoints such as activities of daily life, mobility, social participation, and also falls.

Summary

Our findings show that highly repetitive electromechanical-assisted training is probably the best intervention for improving the walking speed of stroke patients. Walking distance is most likely to be increased by end-effector-assisted training and treadmill training with body-weight support. These results have important consequences for the neurological rehabilitation of stroke patients with impaired walking ability, in that device-supported training must be universally integrated into rehabilitation practice. Furthermore, the findings have considerable implications for the practice of community and inpatient physiotherapy and for the financing of such treatment in the out-of-hospital setting. A change of direction is required—away from special physiotherapy employing neurophysiological techniques (29) towards device-supported walking rehabilitation.

Future studies should investigate both the number of repetitions and the intensity and escalation of treatment in walking rehabilitation for stroke patients. Forthcoming systematic reviews should include individual patient data to enhance the accuracy of description of the effects of walking training.

Supplementary Material

eMethods

Details of methods

Study protocol and registration

We registered a study protocol which has been published in accordance with the PRISMA criteria in the PROSPERO database under the ID CRD42017056820 (23).

Inclusion and exclusion criteria

We included published and unpublished trials on adults following stroke. We compared all types of walking training for improvement in walking speed, walking distance, and walking ability after stroke. All randomized controlled trials with parallel-group design were included, as were all randomized crossover studies that compared walking training with other interventions. We combined comparable interventions and treatment approaches into treatment categories.

Information sources and search

The following databases formed the basis for our survey (search periods in parentheses):

To identify other published and unpublished trials, we searched the following study registers:

In addition, we conducted a hand search of reference lists and bibliographies and scrutinized contributions to the following congresses:

Furthermore, we contacted authors and manufacturers of devices.

The search strategy for MEDLINE is described in the eBox. This strategy was adapted for all other databases.

Study selection

One of us (BE) screened all titles and abstracts and excluded irrelevant studies. We fetched the full texts of the remaining studies. Two of us (BE, JM) decided whether these publications fitted our study question. Any disagreements were settled by discussions involving the complete author group.

Data acquisition process

Two of us (BE and JM) extracted the study data and results.

Data elements

Using checklists, two of us (BE and JM) independently verified the following points:

Geometry of the network

The geometry of the network characterizes the relation and accuracy of the direct comparisons. To enable assessment of network geometry, we produced network diagrams (eFigures 14) (20). Each intervention is represented by a node in the network. Direct comparisons between interventions are shown by lines connecting the nodes.

Risk of bias for the trials included

We assessed the risk of bias using the Cochrane Risk of Bias Tool for the following dimensions:

The results were incorporated into our sensitivity analysis, in which only studies with low risk of bias were considered.

Calculation of effect sizes

When trials used the same test procedure (e.g., walking speed in m/s), we calculated mean differences (MD) and the corresponding 95% confidence intervals (CI). If various result measures were used for a given endpoint, we calculated standardized mean differences (SMD) with 95% CI. For dichotomous endpoints we determined the index of the risk difference (RD) with 95% CI. We generated contrast-based Forest plots for all comparisons. We compiled a relative ranking of the competing interventions on the basis of their surface under the cumulative ranking line (SUCRA) (25). The SUCRA values give the percentage efficacy of each individual intervention in comparison with an “ideal” treatment. All statistical analyses were performed using the software STATA SE Version 15.0 (18, 21).

Analysis method planned and performed

This network meta-analysis was conducted according to a frequentist approach with weighted least squares based on a multivariate regression with random effects. This approach enables adequate consideration of multiple-arm studies and includes restricted maximum-likelihood estimation (26).

Assessment of inconsistency

To test for possible infringement of the transitivity assumption, we assessed global inconsistency by accommodating a consistency and an inconsistency model (24, 26). Transitivity means there are no systematic differences among the various arms of the individual studies. At local level we used the node-splitting approach (22, 26). Alongside the quantitative tests, we performed qualitative verification of the description of the trials included with regard to important effect modifiers.

Risk of bias among the trials

We assessed the risk of bias among the trials for each of the three dimensions (randomization sequence, concealment of randomization sequence, and blinding) as a covariable at study level in network diagrams.

Additional analyses

We viewed generation of the randomization sequence, concealment of the allocation sequence, and blinding of the investigators as potentially important methodological effect modifiers and integrated them into a sensitivity analysis.

Furthermore, for every dependent variable we carried out a meta-regression of the means to identify any further potentially relevant effect modifiers. For this purpose we used walking ability at the beginning of the study and time from stroke event to the beginning of the study.

Presentation of network structure and risk of bias among the trials

The various endpoints (walking speed, walking distance, walking ability, and safety) are depicted in eFigures 14.

Summary of network geometry

Walking speed

The efficacy of various procedures with regard to walking speed was investigated in the following categories:

Walking distance

The efficacy of various procedures with regard to walking distance was investigated in the following categories:

Walking ability

The efficacy of various procedures with regard to walking ability was investigated in the following categories:

Safety

The safety of various procedures was investigated in the following categories:

Estimation of similarity, inconsistency, and heterogeneity

Similarity

Qualitative analysis of all trials included with regard to possible effect modifiers turned up no relevant factors arguing against the assumption of similarity.

Inconsistency and heterogeneity

Walking speed

No signs of global inconsistency were found; the consistency model did not differ statistically significantly from the inconsistency model: Chi² (df = 8) = 8.59; P = 0.38. On local inspection of inconsistency there was no statistically significant inconsistency within the various loops and no important loop-specific heterogeneity. Thus there was no sign of infringement of the consistency and homogeneity assumption.

Walking distance

There were no signs of global inconsistency; the consistency model did not differ statistically significantly from the inconsistency model: Chi² (df = 5) = 2.17; P = 0.83. On local inspection of inconsistency there was no statistically significant inconsistency within the various loops and no important loop-specific heterogeneity. Thus there was no sign of infringement of the consistency and homogeneity assumption.

Walking ability

There were signs of global inconsistency; the consistency model differed statistically significantly from the inconsistency model: Chi² (df = 1) = 4.05; P = 0.04. Local inspection of inconsistency revealed statistically significant inconsistency within the sole analyzable loop—conventional walking rehabilitation–treadmill training with body-weight support and electromechanical-assisted walking training with exoskeleton—(inconsistency factor [IF] = 0.74; 95% CI [0.10; 1.37]) and moderate loop-specific heterogeneity. Thus, infringement of the consistency assumption can be assumed.

Safety

There were no signs of global inconsistency; the consistency model did not differ statistically significantly from the inconsistency model: Chi² (df = 68) = 0.60, P = 1. On local inspection of inconsistency there was no statistically significant inconsistency within the various loops and no important loop-specific heterogeneity. Thus there was no sign of infringement of the consistency and homogeneity assumption.

Results of additional analyses

The sensitivity analysis found no statistically significant effect of internal validity: neither the generation of the randomization sequence nor the concealment of the allocation sequence nor the blinding of the investigators changed the effect estimators significantly.

The meta-regression revealed that neither walking ability at the beginning of the study nor the time from the stroke event to the beginning of the study was a statistically significant effect modifier for the endpoints walking speed, walking distance, walking ability, and safety.

  • CENTRAL; the Cochrane Library (2017, up to edition 8)

  • MEDLINE (1948 to 28 August 2017)

  • EMBASE (1980 to 28 August 2017)

  • CINAHL (1982 to 28 August 2017)

  • AMED (1985 to 28 August 2017)

  • Web of Science (1899 to 28 August 2017)

  • PEDro (to 28 August 2017)

  • COMPENDEX (1972 to 16 November 2012)

  • SPORTDiscus (1949 to 28 August 2017)

  • Rehabdata (to 28 August 2017)

  • International Standard Randomised Controlled Trial Number Register (www.isrctn.com; to 9 March 2017)

  • US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov (www.clinicaltrials.gov; to 9 March 2017),

  • Stroke Trials Register (www.strokecenter.org; to 9 March 2017)

  • World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) (to 9 March 2017).

  • World Congress of NeuroRehabilitation (2006 to 2016)

  • World Congress of Physical Medicine and Rehabilitation (2005 to 2015)

  • World Congress of Physical Therapy (2007 to 2015)

  • Deutsche Gesellschaft für Neurotraumabiologie und Klinische Neurorehabilitation (2005 to 2016)

  • Deutsche Gesellschaft für Neurologie (2005 to 2016)

  • Deutsche Gesellschaft für Neurorehabilitation (2005 to 2016) und Asian Oceania Conference of Physical and Rehabilitation (2008 to 2016).

  • Methods of randomization sequence generation

  • Methods of concealed allocation

  • Blinding of investigators, participants and personnel

  • Adverse events and study drop-outs

  • Important differences in prognostic factors

  • Study participants (number, age, time from stroke occurrence to study inclusion)

  • Description of the interventions in the experimental group and the control group on the basis of the predefined categories.

  • Generation of randomization sequence

  • Concealment of allocation sequence

  • Blinding of investigators (19)

  • No walking rehabilitation (5 study arms with a total of 142 patients)

  • Conventional walking rehabilitation (70 study arms with a total of 1572 patients)

  • Treadmill training (21 study arms with a total of 415 patients)

  • Treadmill training with body-weight support (29 study arms with a total of 913 patients)

  • Electromechanical-assisted walking training with end-effector devices (7 study arms with a total of 252 patients)

  • Electromechanical-assisted walking training with exoskeleton devices (17 study arms with a total of 265 patients)

  • Treadmill training with speed paradigm (2 study arms with a total of 55 patients)

  • No walking rehabilitation (5 study arms with a total of 105 patients)

  • Conventional walking rehabilitation (40 study arms with a total of 1066 patients)

  • Treadmill training (11 study arms with a total of 230 patients)

  • Treadmill training with body-weight support (19 study arms with a total of 748 patients)

  • Electromechanical-assisted walking training with end-effector devices (5 study arms with a total of 216 patients)

  • Electromechanical-assisted walking training with exoskeleton devices (8 study arms with a total of 129 patients)

  • Treadmill training with speed paradigm (1 study arm with 15 patients)

  • Conventional walking rehabilitation (21 study arms with a total of 658 patients)

  • Treadmill training (1 study arm with 15 patients)

  • Treadmill training with body-weight support (7 study arms with a total of 465 patients)

  • Electromechanical-assisted walking training with end-effector devices (6 study arms with a total of 201 patients)

  • Electromechanical-assisted walking training with exoskeleton devices (9 study arms with a total of 178 patients)

  • No walking rehabilitation (5 study arms with a total of 102 patients)

  • Conventional walking rehabilitation (50 study arms with a total of 1156 patients)

  • Treadmill training (12 study arms with a total of 228 patients)

  • Treadmill training with body-weight support (12 study arms with a total of 620 patients)

  • Electromechanical-assisted walking training with end-effector devices (10 study arms with a total of 305 patients)

  • Electromechanical-assisted walking training with exoskeleton devices (24 study arms with a total of 434 patients)

  • Treadmill training with speed paradigm (1 study arm with 44 patients)

The Clinical Perspective.

Walking speed and walking distance are important clinical endpoints for walking ability following stroke. Both walking speed and walking distance in stroke patients were enhanced particularly by the use of electromechanical-assisted end-effector devices to move the legs. The clinical improvement was superior to that achieved by conventional rehabilitation techniques. Major clinical improvement can also be achieved by means of treadmill training with partial body-weight support. To improve the clinically important aspects of walking in practice, we recommend end-effector devices providing assistance from distal, rather than completely electromechanical-assisted exoskeleton devices.

It emerged that the use of electromechanical-assisted devices in stroke patients may have clinical advantages over walking rehabilitation without such devices. The added benefit probably lies in the fact that even patients who are unable to walk achieve more repetitions with a device than without. The effects we found can best be explained by assuming that patients whose movements are led to an excessive degree fail to improve in terms of clinically significant parameters of walking. This is in accord with currently prevailing theories about the relearning of motor skills following stroke.

Key Messages.

  • To date, 95 randomized controlled trials have described the treatment effects of walking training following stroke on clinically significant parameters of ambulation such as walking speed and walking distance.

  • Both walking speed and walking distance seem to be improved more effectively by electromechanical-assisted end-effector devices that move the patient’s legs from distal, and by treadmill training with body-weight support, than by conventional walking rehabilitation.

  • For methodological reasons, no conclusions can be drawn with regard to walking ability.

  • There are no major safety differences among the various interventions for walking rehabilitation following stroke.

eFigure 4.

Network diagram for the secondary endpoint safety

eFigure 4

Each intervention is presented as a node in the network. Direct comparisons between interventions are represented by the lines connecting the nodes.

Network plot of the evidence net of randomized trials for improvement of safety following stroke (57 trials with 2889 patients): The blue circles (nodes) represent the different treatment methods, while the connecting lines show the available direct pairwise comparisons between treatment methods. The assignment of interventions to nodes is as listed in the eMethods. The size of each node is proportional to the number of studies, and the thickness of the lines proportional to the inverse of the standard error of the comparisons. The colors of the lines show the mean risk of bias as measured with the Cochrane Risk of Bias Tool (green: low risk of bias; yellow: unclear risk of bias; red: high risk of bias).

KON Conventional walking rehabilitation
NONE No walking rehabilitation
TT_STT Treadmill training with speed paradigm
EGAIT_EXO Electromechanical-assisted training with exoskeleton
EGAIT_EE Electromechanical-assisted training with end-effector
TT_BWS Treadmill training with body-weight support
TT Treadmill training

eTable 6. SUCRA for the secondary endpoint walking distance.

Intervention SUCRA
Electromechanical-assisted walking training with end-effector 86.7
Treadmill training with body-weight support 76.8
Treadmill training 57.4
Treadmill training with speed paradigm 49.0
No walking rehabilitation 39.5
Electromechanical-assisted walking training with exoskeleton 20.8
Conventional walking rehabilitation 19.9

SUCRA is a relative ranking of the competing interventions on the basis of their surface under the cumulative ranking line. This represents the percent efficacy or safety of a given treatment in relation to an “ideal” treatment.

eBOX. Search strategy.

The following strategy was used for the MEDLINE search via OvidSP and in modified form for the searches in the remaining databases:

  • 1.

    exp cerebrovascular disorders/ or brain injuries/ or brain injury, chronic/

  • 2.

    (stroke$ or cva or poststroke or post-stroke).tw.

  • 3.

    (cerebrovasc$ or cerebral vascular).tw.

  • 4.

    (cerebral or cerebellar or brain$ or vertebrobasilar).tw.

  • 5.

    (infarct$ or isch?emi$ or thrombo$ or emboli$ or apoplexy).tw.

  • 6.

    4 and 5

  • 7.

    (cerebral or brain or subarachnoid).tw.

  • 8.

    (haemorrhage or hemorrhage or haematoma or hematoma or bleed$).tw.

  • 9.

    7 and 8

  • 10.

    hemiplegia/ or exp paresis/

  • 11.

    (hempar$ or hemipleg$ or brain injur$).tw.

  • 12.

    Gait Disorders, Neurologic/

  • 13.

    1 or 2 or 3 or 6 or 9 or 10 or 11 or 12

  • 14.

    physical therapy modalities/ or exercise therapy/ or motion therapy, continuous passive/ or musculoskeletal manipulations/

  • 15.

    *exercise/ or *exercise test/ or exercise therapy/ or motion therapy, continuous passive/

  • 16.

    robotics/ or automation/ or orthotic devices/ or man-machine systems/ or self-help devices/ or therapy, computer-assisted/

  • 17.

    body weight/ or weight-bearing/

  • 18.

    ((gait or locomot$) adj5 (train$ or therapy or rehabilitat$ or re-educat$ or machine$ or powered or device$)).tw.

  • 19.

    (electromechanical or electro-mechanical or mechanical or mechanised or mechanized or driven or assistive device$).tw.

  • 20.

    ((body-weight or body weight) adj3 (support$ or relief)).tw.

  • 21.

    (robot$ or orthos$ or orthotic or automat$ or computer aided or computer assisted or power-assist$).tw.

  • 22.

    (bws or harness or treadmill or exercise$ or fitness train$ or Lokomat or Locomat or GaiTrainer or GT1 or Kinetron or Haptic Walker or Anklebot or LOPES or AutoAmbulator).tw.

  • 23.

    ((continuous passive or cpm) adj3 therap$).tw.

  • 24.

    or/14–23

  • 25.

    gait/ or exp walking/ or locomotion/

  • 26.

    „Range of Motion, Articular“/

  • 27.

    recovery of function/

  • 28.

    (walk$ or gait$ or ambulat$ or mobil$ or locomot$ or balanc$ or stride).tw.

  • 29.

    or/25–28

  • 30.

    body weight/ or weight-bearing/

  • 31.

    (treadmill$ or tread mill$ or running wheel$ or running machine$).tw.

  • 32.

    ((walking or walk or exercise) adj5 (machine$ or device$)).tw.

  • 33.

    ((walking or gait or locomotor or ambulation) adj5 (train$ or re-train$ or retrain$)).tw.

  • 34.

    exp walking/ and (machine$ or device$ or train$ or re-train$ or retrain$).tw.

  • 35.

    ((weight or body-weight or bodyweight) adj5 (support$ or suspen$ or relief)).tw.

  • 36.

    ((walk or walking or ambulat$ or locomot$ or gait or overhead) adj5 support$).tw.

  • 37.

    harness$.tw.

  • 38.

    or/30–37

  • 39.

    exp walking/ or gait/ or mobility limitation/ or locomotion/ or exercise movement techniques/

  • 40.

    (walk$ or gait$ or ambulat$ or mobil$ or locomot$ or stride).tw.

  • 41.

    39 or 40

  • 42.

    (overground or over ground or surface or floor).tw.

  • 43.

    24 or 29 or 38 or 41 or 42

  • 44.

    Randomized Controlled Trials as Topic/

  • 45.

    random allocation/

  • 46.

    Controlled Clinical Trials as Topic/

  • 47.

    controlgroups/

  • 48.

    clinical trials as topic/ or clinical trials, phase i as topic/ or clinical trials, phase ii as topic/ or clinical trials, phase iii as topic/ or clinical trials, phase iv as topic/

  • 49.

    double-blind method/

  • 50.

    single-blind method/

  • 51.

    Placebos/

  • 52.

    placebo effect/

  • 53.

    cross-over studies/

  • 54.

    Therapies, Investigational/

  • 55.

    Research Design/

  • 56.

    evaluation studies as topic/

  • 57.

    randomized controlled trial.pt.

  • 58.

    controlled clinical trial.pt.

  • 59.

    (clinical trial or clinical trial phase i or clinical trial phase ii or clinical trial phase iii or clinical trial phase iv).pt.

  • 60.

    (evaluation studies or comparative study).pt.

  • 61.

    random$.tw.

  • 62.

    (controlled adj5 (trial$ or stud$)).tw.

  • 63.

    (clinical$ adj5 trial$).tw.

  • 64.

    ((control or treatment or experiment$ or intervention) adj5 (group$ or subject$ or patient$)).tw.

  • 65.

    (quasi-random$ or quasi random$ or pseudo-random$ or pseudo random$).tw.

  • 66.

    ((multicenter or multicentre or therapeutic) adj5 (trial$ or stud$)).tw.

  • 67.

    ((control or experiment$ or conservative) adj5 (treatment or therapy or procedure or manage$)).tw.

  • 68.

    ((singl$ or doubl$ or tripl$ or trebl$) adj5 (blind$ or mask$)).tw.

  • 69.

    (coin adj5 (flip or flipped or toss$)).tw.

  • 70.

    versus.tw.

  • 71.

    (cross-over or cross over or crossover).tw.

  • 72.

    placebo$.tw.

  • 73.

    Sham.tw.

  • 74.

    (assign$ or alternate or allocat$ or counterbalance$ or multiple baseline).tw.

  • 75.

    or/31–61

  • 76.

    13 and 43 and 75

  • 77.

    exp animals/ not humans.sh.

  • 78.

    76 not 77

Acknowledgments

Translated from the original German by David Roseveare

Footnotes

Conflict of interest statement

The authors declare that no conflict of interest exists.

References

  • 1.Hesse S, Mehrholz J, Werner C. Robot-assisted upper and lower limb rehabilitation after stroke. Dtsch Arztebl Int. 2008;105:330–336. doi: 10.3238/arztebl.2008.0330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Dohle C, Tholen R, Wittenberg H, Saal S, Quintern J, Stephan K. S2e-Leitlinie: Rehabilitation der Mobilität nach Schlaganfall (ReMoS) Neurologie und Rehabilitation. 2015;21:355–494. [Google Scholar]
  • 3.Mehrholz J, Thomas S, Elsner B. Treadmill training and body weight support for walking after stroke. Cochrane Database Syst Rev. 2017 doi: 10.1002/14651858.CD002840.pub4. CD002840. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Mehrholz J, Thomas S, Pohl M, Werner C, Kugler J, Elsner B. Electromechanical-assisted training for walking after stroke. Cochrane Database Syst Rev. 2017 doi: 10.1002/14651858.CD006185.pub4. CD006185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Pohl M, Mehrholz J, Ritschel C, Ruckriem S. Speed-dependent treadmill training in ambulatory hemiparetic stroke patients: a randomized controlled trial. Stroke. 2002;33:553–558. doi: 10.1161/hs0202.102365. [DOI] [PubMed] [Google Scholar]
  • 6.Mehrholz J, Pohl M. Electromechanical-assisted gait training after stroke A systematic review comparing endeffector and exoskeleton devices. J Rehabil Med. 2012;44:193–199. doi: 10.2340/16501977-0943. [DOI] [PubMed] [Google Scholar]
  • 7.Werner C, von Frankenberg S, Treig T, Konrad M, Hesse S. Treadmill training with partial body weight support and an electromechanical gait trainer for restoration of gait in subacute stroke patients: a randomized crossover study. Stroke. 2002;33:2895–2901. doi: 10.1161/01.str.0000035734.61539.f6. [DOI] [PubMed] [Google Scholar]
  • 8.Colombo G, Joerg M, Schreier R, Dietz V. Treadmill training of paraplegic patients using a robotic orthosis. J Rehabil Res Dev. 2000;37:693–700. [PubMed] [Google Scholar]
  • 9.Buesing C, Fisch G, O‘Donnell M, et al. Effects of a wearable exoskeleton stride management assist system (SMA) on spatiotemporal gait characteristics in individuals after stroke: a randomized controlled trial. J Neuroeng Rehabil. 2015;12 doi: 10.1186/s12984-015-0062-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Stein J, Bishop L, Stein DJ, Wong CK. Gait training with a robotic leg brace after stroke. Am J Phys Med Rehabil. 2014;93:987–994. doi: 10.1097/PHM.0000000000000119. [DOI] [PubMed] [Google Scholar]
  • 11.Watanabe H, Tanaka N, Inuta T, Saitou H, Yanagi H. Locomotion improvement using a hybrid assistive limb in recovery phase stroke patients: a randomized controlled pilot study. Arch Phys Med Rehabil. 2014;95:2006–2212. doi: 10.1016/j.apmr.2014.07.002. [DOI] [PubMed] [Google Scholar]
  • 12.Forrester LW, Roy A, Hafer-Macko C, Krebs HI, Macko RF. Task-specific ankle robotics gait training after stroke: a randomized pilot study. J Neuroeng Rehabil. 2016;13 doi: 10.1186/s12984-016-0158-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Forrester LW, Roy A, Krywonis A, Kehs G, Krebs HI, Macko RF. Modular ankle robotics training in early subacute stroke: a randomized controlled pilot study. Neurorehabil Neural Repair. 2014;28:678–687. doi: 10.1177/1545968314521004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Waldman G, Yang CY, Ren Y, et al. Effects of robot-guided passive stretching and active movement training of ankle and mobility impairments in stroke. NeuroRehabilitation. 2013;32:625–634. doi: 10.3233/NRE-130885. [DOI] [PubMed] [Google Scholar]
  • 15.Mehrholz J, Thomas S, Elsner B. Treadmill training and body weight support for walking after stroke. Cochrane Database Syst Rev. 2017 doi: 10.1002/14651858.CD002840.pub4. CD002840. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Mills EJ, Bansback N, Ghement I, et al. Multiple treatment comparison meta-analyses: a step forward into complexity. Clin Epidemiol. 2011;3:193–202. doi: 10.2147/CLEP.S16526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Hutton B, Salanti G, Caldwell DM, et al. The prisma extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162:777–784. doi: 10.7326/M14-2385. [DOI] [PubMed] [Google Scholar]
  • 18.StataCorp LLC. Stata Statistical Software: Release 15 College Station, TX, 2017. www.stata.com/features/documentation/ (last accessed on 1 March 2018) [Google Scholar]
  • 19.Higgins JPT, Altman DG, Sterne JAC. Higgins JPT, Green S, editors. Assessing risk of bias in included studies Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane-handbook.org (last accessed on 1 March 2018) [Google Scholar]
  • 20.Chaimani A, Higgins JP, Mavridis D, Spyridonos P, Salanti G. Graphical tools for network meta-analysis in STATA. PLoS One. 2013;8 doi: 10.1371/journal.pone.0076654. e76654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Chaimani A, Salanti G. Visualizing assumptions and results in network meta-analysis: the network graphs package. Stata J. 2015;15:905–950. [Google Scholar]
  • 22.Dias S, Welton NJ, Caldwell DM, Ades AE. Checking consistency in mixed treatment comparison meta-analysis. Stat Med. 2010;29:932–944. doi: 10.1002/sim.3767. [DOI] [PubMed] [Google Scholar]
  • 23.Hutton B, Salanti G, Caldwell DM, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162:777–784. doi: 10.7326/M14-2385. [DOI] [PubMed] [Google Scholar]
  • 24.Kiefer C, Sturtz S, Bender R. Indirect comparisons and network meta-analyses: estimation of effects in the absence of head-to-head trials—part 22 of a series on evaluation of scientific publications. Dtsch Arztebl Int. 2015;112:803–808. doi: 10.3238/arztebl.2015.0803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Salanti G, Ades AE, Ioannidis JP. Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. J Clin Epidemiol. 2011;64:163–171. doi: 10.1016/j.jclinepi.2010.03.016. [DOI] [PubMed] [Google Scholar]
  • 26.White IR, Barrett JK, Jackson D, Higgins JP. Consistency and inconsistency in network meta-analysis: model estimation using multivariate meta-regression. Res Synth Methods. 2012;3:111–125. doi: 10.1002/jrsm.1045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Flansbjer UB, Holmback AM, Downham D, Patten C, Lexell J. Reliability of gait performance tests in men and women with hemiparesis after stroke. J Rehabil Med. 2005;37:75–82. doi: 10.1080/16501970410017215. [DOI] [PubMed] [Google Scholar]
  • 28.French B, Thomas LH, Coupe J, et al. Repetitive task training for improving functional ability after stroke. Cochrane Database Syst Rev. 2016;11 doi: 10.1002/14651858.CD006073.pub3. CD006073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Heilmittelkatalog. www.heilmittelkatalog.de/files/luxe/hmkonline/physio/zn2.htm (last accessed on 1 May 2018) 2017 [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

eMethods

Details of methods

Study protocol and registration

We registered a study protocol which has been published in accordance with the PRISMA criteria in the PROSPERO database under the ID CRD42017056820 (23).

Inclusion and exclusion criteria

We included published and unpublished trials on adults following stroke. We compared all types of walking training for improvement in walking speed, walking distance, and walking ability after stroke. All randomized controlled trials with parallel-group design were included, as were all randomized crossover studies that compared walking training with other interventions. We combined comparable interventions and treatment approaches into treatment categories.

Information sources and search

The following databases formed the basis for our survey (search periods in parentheses):

To identify other published and unpublished trials, we searched the following study registers:

In addition, we conducted a hand search of reference lists and bibliographies and scrutinized contributions to the following congresses:

Furthermore, we contacted authors and manufacturers of devices.

The search strategy for MEDLINE is described in the eBox. This strategy was adapted for all other databases.

Study selection

One of us (BE) screened all titles and abstracts and excluded irrelevant studies. We fetched the full texts of the remaining studies. Two of us (BE, JM) decided whether these publications fitted our study question. Any disagreements were settled by discussions involving the complete author group.

Data acquisition process

Two of us (BE and JM) extracted the study data and results.

Data elements

Using checklists, two of us (BE and JM) independently verified the following points:

Geometry of the network

The geometry of the network characterizes the relation and accuracy of the direct comparisons. To enable assessment of network geometry, we produced network diagrams (eFigures 14) (20). Each intervention is represented by a node in the network. Direct comparisons between interventions are shown by lines connecting the nodes.

Risk of bias for the trials included

We assessed the risk of bias using the Cochrane Risk of Bias Tool for the following dimensions:

The results were incorporated into our sensitivity analysis, in which only studies with low risk of bias were considered.

Calculation of effect sizes

When trials used the same test procedure (e.g., walking speed in m/s), we calculated mean differences (MD) and the corresponding 95% confidence intervals (CI). If various result measures were used for a given endpoint, we calculated standardized mean differences (SMD) with 95% CI. For dichotomous endpoints we determined the index of the risk difference (RD) with 95% CI. We generated contrast-based Forest plots for all comparisons. We compiled a relative ranking of the competing interventions on the basis of their surface under the cumulative ranking line (SUCRA) (25). The SUCRA values give the percentage efficacy of each individual intervention in comparison with an “ideal” treatment. All statistical analyses were performed using the software STATA SE Version 15.0 (18, 21).

Analysis method planned and performed

This network meta-analysis was conducted according to a frequentist approach with weighted least squares based on a multivariate regression with random effects. This approach enables adequate consideration of multiple-arm studies and includes restricted maximum-likelihood estimation (26).

Assessment of inconsistency

To test for possible infringement of the transitivity assumption, we assessed global inconsistency by accommodating a consistency and an inconsistency model (24, 26). Transitivity means there are no systematic differences among the various arms of the individual studies. At local level we used the node-splitting approach (22, 26). Alongside the quantitative tests, we performed qualitative verification of the description of the trials included with regard to important effect modifiers.

Risk of bias among the trials

We assessed the risk of bias among the trials for each of the three dimensions (randomization sequence, concealment of randomization sequence, and blinding) as a covariable at study level in network diagrams.

Additional analyses

We viewed generation of the randomization sequence, concealment of the allocation sequence, and blinding of the investigators as potentially important methodological effect modifiers and integrated them into a sensitivity analysis.

Furthermore, for every dependent variable we carried out a meta-regression of the means to identify any further potentially relevant effect modifiers. For this purpose we used walking ability at the beginning of the study and time from stroke event to the beginning of the study.

Presentation of network structure and risk of bias among the trials

The various endpoints (walking speed, walking distance, walking ability, and safety) are depicted in eFigures 14.

Summary of network geometry

Walking speed

The efficacy of various procedures with regard to walking speed was investigated in the following categories:

Walking distance

The efficacy of various procedures with regard to walking distance was investigated in the following categories:

Walking ability

The efficacy of various procedures with regard to walking ability was investigated in the following categories:

Safety

The safety of various procedures was investigated in the following categories:

Estimation of similarity, inconsistency, and heterogeneity

Similarity

Qualitative analysis of all trials included with regard to possible effect modifiers turned up no relevant factors arguing against the assumption of similarity.

Inconsistency and heterogeneity

Walking speed

No signs of global inconsistency were found; the consistency model did not differ statistically significantly from the inconsistency model: Chi² (df = 8) = 8.59; P = 0.38. On local inspection of inconsistency there was no statistically significant inconsistency within the various loops and no important loop-specific heterogeneity. Thus there was no sign of infringement of the consistency and homogeneity assumption.

Walking distance

There were no signs of global inconsistency; the consistency model did not differ statistically significantly from the inconsistency model: Chi² (df = 5) = 2.17; P = 0.83. On local inspection of inconsistency there was no statistically significant inconsistency within the various loops and no important loop-specific heterogeneity. Thus there was no sign of infringement of the consistency and homogeneity assumption.

Walking ability

There were signs of global inconsistency; the consistency model differed statistically significantly from the inconsistency model: Chi² (df = 1) = 4.05; P = 0.04. Local inspection of inconsistency revealed statistically significant inconsistency within the sole analyzable loop—conventional walking rehabilitation–treadmill training with body-weight support and electromechanical-assisted walking training with exoskeleton—(inconsistency factor [IF] = 0.74; 95% CI [0.10; 1.37]) and moderate loop-specific heterogeneity. Thus, infringement of the consistency assumption can be assumed.

Safety

There were no signs of global inconsistency; the consistency model did not differ statistically significantly from the inconsistency model: Chi² (df = 68) = 0.60, P = 1. On local inspection of inconsistency there was no statistically significant inconsistency within the various loops and no important loop-specific heterogeneity. Thus there was no sign of infringement of the consistency and homogeneity assumption.

Results of additional analyses

The sensitivity analysis found no statistically significant effect of internal validity: neither the generation of the randomization sequence nor the concealment of the allocation sequence nor the blinding of the investigators changed the effect estimators significantly.

The meta-regression revealed that neither walking ability at the beginning of the study nor the time from the stroke event to the beginning of the study was a statistically significant effect modifier for the endpoints walking speed, walking distance, walking ability, and safety.

  • CENTRAL; the Cochrane Library (2017, up to edition 8)

  • MEDLINE (1948 to 28 August 2017)

  • EMBASE (1980 to 28 August 2017)

  • CINAHL (1982 to 28 August 2017)

  • AMED (1985 to 28 August 2017)

  • Web of Science (1899 to 28 August 2017)

  • PEDro (to 28 August 2017)

  • COMPENDEX (1972 to 16 November 2012)

  • SPORTDiscus (1949 to 28 August 2017)

  • Rehabdata (to 28 August 2017)

  • International Standard Randomised Controlled Trial Number Register (www.isrctn.com; to 9 March 2017)

  • US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov (www.clinicaltrials.gov; to 9 March 2017),

  • Stroke Trials Register (www.strokecenter.org; to 9 March 2017)

  • World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) (to 9 March 2017).

  • World Congress of NeuroRehabilitation (2006 to 2016)

  • World Congress of Physical Medicine and Rehabilitation (2005 to 2015)

  • World Congress of Physical Therapy (2007 to 2015)

  • Deutsche Gesellschaft für Neurotraumabiologie und Klinische Neurorehabilitation (2005 to 2016)

  • Deutsche Gesellschaft für Neurologie (2005 to 2016)

  • Deutsche Gesellschaft für Neurorehabilitation (2005 to 2016) und Asian Oceania Conference of Physical and Rehabilitation (2008 to 2016).

  • Methods of randomization sequence generation

  • Methods of concealed allocation

  • Blinding of investigators, participants and personnel

  • Adverse events and study drop-outs

  • Important differences in prognostic factors

  • Study participants (number, age, time from stroke occurrence to study inclusion)

  • Description of the interventions in the experimental group and the control group on the basis of the predefined categories.

  • Generation of randomization sequence

  • Concealment of allocation sequence

  • Blinding of investigators (19)

  • No walking rehabilitation (5 study arms with a total of 142 patients)

  • Conventional walking rehabilitation (70 study arms with a total of 1572 patients)

  • Treadmill training (21 study arms with a total of 415 patients)

  • Treadmill training with body-weight support (29 study arms with a total of 913 patients)

  • Electromechanical-assisted walking training with end-effector devices (7 study arms with a total of 252 patients)

  • Electromechanical-assisted walking training with exoskeleton devices (17 study arms with a total of 265 patients)

  • Treadmill training with speed paradigm (2 study arms with a total of 55 patients)

  • No walking rehabilitation (5 study arms with a total of 105 patients)

  • Conventional walking rehabilitation (40 study arms with a total of 1066 patients)

  • Treadmill training (11 study arms with a total of 230 patients)

  • Treadmill training with body-weight support (19 study arms with a total of 748 patients)

  • Electromechanical-assisted walking training with end-effector devices (5 study arms with a total of 216 patients)

  • Electromechanical-assisted walking training with exoskeleton devices (8 study arms with a total of 129 patients)

  • Treadmill training with speed paradigm (1 study arm with 15 patients)

  • Conventional walking rehabilitation (21 study arms with a total of 658 patients)

  • Treadmill training (1 study arm with 15 patients)

  • Treadmill training with body-weight support (7 study arms with a total of 465 patients)

  • Electromechanical-assisted walking training with end-effector devices (6 study arms with a total of 201 patients)

  • Electromechanical-assisted walking training with exoskeleton devices (9 study arms with a total of 178 patients)

  • No walking rehabilitation (5 study arms with a total of 102 patients)

  • Conventional walking rehabilitation (50 study arms with a total of 1156 patients)

  • Treadmill training (12 study arms with a total of 228 patients)

  • Treadmill training with body-weight support (12 study arms with a total of 620 patients)

  • Electromechanical-assisted walking training with end-effector devices (10 study arms with a total of 305 patients)

  • Electromechanical-assisted walking training with exoskeleton devices (24 study arms with a total of 434 patients)

  • Treadmill training with speed paradigm (1 study arm with 44 patients)


Articles from Deutsches Ärzteblatt International are provided here courtesy of Deutscher Arzte-Verlag GmbH

RESOURCES